TWI627210B - Cured film forming composition, alignment material and retardation material - Google Patents

Cured film forming composition, alignment material and retardation material Download PDF

Info

Publication number
TWI627210B
TWI627210B TW102110902A TW102110902A TWI627210B TW I627210 B TWI627210 B TW I627210B TW 102110902 A TW102110902 A TW 102110902A TW 102110902 A TW102110902 A TW 102110902A TW I627210 B TWI627210 B TW I627210B
Authority
TW
Taiwan
Prior art keywords
group
component
alignment
cured film
forming composition
Prior art date
Application number
TW102110902A
Other languages
Chinese (zh)
Other versions
TW201404816A (en
Inventor
畑中真
石田智久
湯川昇志郎
Original Assignee
日產化學工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日產化學工業股份有限公司 filed Critical 日產化學工業股份有限公司
Publication of TW201404816A publication Critical patent/TW201404816A/en
Application granted granted Critical
Publication of TWI627210B publication Critical patent/TWI627210B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D4/00Coating compositions, e.g. paints, varnishes or lacquers, based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond ; Coating compositions, based on monomers of macromolecular compounds of groups C09D183/00 - C09D183/16
    • C09D4/06Organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond in combination with a macromolecular compound other than an unsaturated polymer of groups C09D159/00 - C09D187/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/54Silicon-containing compounds
    • C08K5/544Silicon-containing compounds containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08Cellulose derivatives
    • C09D101/26Cellulose ethers
    • C09D101/28Alkyl ethers
    • C09D101/284Alkyl ethers with hydroxylated hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D133/00Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
    • C09D133/04Homopolymers or copolymers of esters
    • C09D133/06Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C09D133/062Copolymers with monomers not covered by C09D133/06
    • C09D133/066Copolymers with monomers not covered by C09D133/06 containing -OH groups
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D201/00Coating compositions based on unspecified macromolecular compounds
    • C09D201/02Coating compositions based on unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/30Polarising elements
    • G02B5/3016Polarising elements involving passive liquid crystal elements
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2312/00Crosslinking

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Liquid Crystal (AREA)
  • Paints Or Removers (AREA)
  • Polarising Elements (AREA)

Abstract

本發明提供一種形成具備優異之光反應效率及耐溶劑性與高密著性之硬化膜的硬化膜形成組成物,且提供光配向用之配向材及使用該配向材所形成之相位差材。 The present invention provides a cured film forming composition that forms a cured film having excellent photoreaction efficiency, solvent resistance, and high adhesion, and provides an alignment material for optical alignment and a phase difference material formed using the alignment material.

本發明之硬化膜形成組成物係含有(A)具有光配向性基與由羥基、羧基及胺基選出之任一個取代基之化合物、(B)具有由羥基、羧基及胺基選出之一種或兩種以上之取代基之親水性聚合物、以及(C)具有胺基之烷氧基矽烷化合物。使用此硬化膜形成組成物形成硬化膜,利用光配向技術形成配向材。將聚合性液晶塗佈於配向材上,使其硬化獲得相位差材。 The cured film forming composition of the present invention contains (A) a compound having a photo-alignment group and any substituent selected from a hydroxyl group, a carboxyl group and an amine group, and (B) has one selected from a hydroxyl group, a carboxyl group and an amine group or Hydrophilic polymers with two or more substituents, and (C) alkoxysilane compounds with amine groups. This cured film forming composition is used to form a cured film, and an alignment material is formed using a photo alignment technique. The polymerizable liquid crystal is coated on the alignment material and hardened to obtain a phase difference material.

Description

硬化膜形成組成物、配向材及相位差材 Hardened film forming composition, alignment material and phase difference material

本發明係關於硬化膜形成組成物、配向材及相位差材。 The present invention relates to a cured film forming composition, an alignment material, and a phase difference material.

近年來,使用液晶面板之電視等之顯示器領域中,已進展可享受3D影像之3D顯示器之開發作為朝向高性能化之取向。3D顯示器係藉由例如以觀察者之右眼辨識右眼用影像,以觀察者之左眼辨識左眼用影像,而可顯示立體感之影像。 In recent years, in the field of displays such as televisions using liquid crystal panels, the development of 3D displays that can enjoy 3D images has progressed as an orientation toward higher performance. The 3D display can display a three-dimensional image by recognizing the right-eye image with the observer's right eye and the left-eye image with the observer's left eye, for example.

顯示3D影像之3D顯示器之方式有多樣者,作為不須專用眼鏡之方式,已知有柱狀透鏡(lenticular lens)方式及視差屏障(parallax barrier)方式等。 There are various ways of displaying 3D images for 3D displays. As a method that does not require special glasses, a lenticular lens method and a parallax barrier method are known.

而且,作為觀察者配戴眼鏡觀察3D影像之顯示器之方式之一已知有圓偏光眼鏡方式等(參照例如專利文獻1)。 In addition, as one of the ways in which the observer wears glasses to observe a 3D image, a circularly polarized glasses method is known (see, for example, Patent Document 1).

圓偏光眼鏡方式之3D顯示器之情況,通常在 液晶面板等之形成影像之顯示元件上配置相位差材。該相位差材係分別複數、規則地配置相位差特性不同之2種相位差區域,構成經圖型化之相位差材。又,以下,本說明書中,將配置此種相位差特性不同之複數個相位差區域之方式而圖型化之相位差材稱為圖型化相位差材。 The case of 3D displays with circular polarized glasses is usually A phase difference material is arranged on a display element forming an image such as a liquid crystal panel. The phase difference material is a plurality of phase difference regions with different phase difference characteristics that are plurally and regularly arranged to form a patterned phase difference material. In the following description, in this specification, a patterned phase difference material that is patterned by disposing a plurality of phase difference regions having different phase difference characteristics is referred to as a patterned phase difference material.

圖型化相位差材係如專利文獻2所揭示,可藉由使由聚合性液晶所成之相位差材料進行光學圖型化而製作。由聚合性液晶所成之相位差材料之光學圖型化係利用於液晶面板之配向材形成中已知之光配向技術。亦即,於基板上設置由光配向性之材料所成之塗膜,對其照射偏光方向不同之2種偏光。接著,形成液晶之配向控制方向不同之2種液晶配向區域,獲得作為配向材之光配向膜。於該光配向膜上塗佈包含聚合性液晶之溶液狀之相位差材料,而實現聚合性液晶之配向。隨後,使經配向之聚合性液晶硬化,形成圖型化相位差材。 The patterned retardation material is disclosed in Patent Document 2, and can be produced by optically patterning a retardation material made of polymerizable liquid crystal. The optical patterning of the phase difference material made of polymerizable liquid crystal is using the optical alignment technique known in the formation of alignment materials for liquid crystal panels. That is, a coating film made of a photo-alignable material is provided on the substrate, and two types of polarized light with different polarized directions are irradiated to the substrate. Next, two types of liquid crystal alignment regions having different alignment control directions of liquid crystals are formed to obtain a light alignment film as an alignment material. A solution phase retardation material containing polymerizable liquid crystal is coated on the optical alignment film to achieve alignment of the polymerizable liquid crystal. Subsequently, the aligned polymerizable liquid crystal is hardened to form a patterned retardation material.

使用液晶面板之光配向技術之配向材形成中,作為可利用之光配向性之材料,已知有側鏈具有桂皮醯基(cinnamoyl)及查爾酮(chalcone)基等之光二聚化部位之丙烯酸樹脂或聚醯亞胺樹脂等。已報導該等樹脂藉由偏光UV照射,而顯示控制液晶配向之性能(以下亦稱為液晶配向性)(參照專利文獻3至專利文獻5)。 In the formation of alignment materials using the optical alignment technology of the liquid crystal panel, as materials that can be used for optical alignment, it is known that the side chain has a photodimerization site such as a cinnamoyl group and a chalcone group. Acrylic resin or polyimide resin, etc. It has been reported that these resins exhibit the performance of controlling liquid crystal alignment (hereinafter also referred to as liquid crystal alignment) by polarized UV irradiation (refer to Patent Documents 3 to 5).

[先前技術文獻] [Prior Technical Literature] [專利文獻] [Patent Literature]

專利文獻1:特開平10-232365號公報 Patent Literature 1: Japanese Patent Laid-Open No. 10-232365

專利文獻2:特開2005-49865號公報 Patent Literature 2: Japanese Patent Laid-Open No. 2005-49865

專利文獻3:日本專利第3611342號公報 Patent Document 3: Japanese Patent No. 3611342

專利文獻4:特開2009-058584號公報 Patent Document 4: JP 2009-058584

專利文獻5:特表2001-517719號公報 Patent Literature 5: Special Table No. 2001-517719

然而,依據本發明人之檢討,了解到將此種於側鏈上具有桂皮醯基或查爾酮基等之光二聚化部位之丙烯酸樹脂適用於相位差材之形成時無法獲得充分之特性。尤其,為了對該等樹脂照射偏光UV形成配向材,使用此配向材進行由聚合性液晶所成之相位差材料之光學圖型化,需要大的偏光UV曝光量。此偏光UV曝光量比使通常之液晶面板用之液晶進行配向即已足夠之偏光UV曝光量(例如,100mJ/cm2左右)格外多。 However, according to the review by the present inventors, it has been found that when such an acrylic resin having a photodimerization site such as a cinnamyl acetyl group or a chalcone group on the side chain is applied to the formation of a phase difference material, sufficient characteristics cannot be obtained. In particular, in order to irradiate the resin with polarized UV to form an alignment material, using this alignment material for optical patterning of a phase difference material made of polymerizable liquid crystal requires a large amount of polarized UV exposure. This polarized UV exposure amount is more than the polarized UV exposure amount (for example, about 100 mJ / cm 2 ) that is sufficient for aligning liquid crystals used in ordinary liquid crystal panels.

偏光UV曝光量增多的理由列舉為相位差材形成時,與液晶面板用之液晶不同,聚合性液晶係以溶液狀態使用,並塗佈於配向材上。 The reason why the amount of polarized UV exposure is increased is that when the phase difference material is formed, unlike the liquid crystal used for the liquid crystal panel, the polymerizable liquid crystal is used in a solution state, and is coated on the alignment material.

使用側鏈上具有桂皮醯基等之光二聚化部位之丙烯酸樹脂等形成配向材,使聚合性液晶進行配向時,此丙烯酸樹脂等係以光二聚化反應進行光交聯。而且,有必要進行大的曝光量之偏光照射直到展現對聚合性液晶溶液之耐性為止。為使液晶面板之液晶配向,通常只要僅使 光配向性之配向材之表面進行二聚化反應即可。然而,使用上述之丙烯酸樹脂等過去材料而使配向材展現耐溶劑性時,有必要反應到配向材之內部,變得需要更多曝光量。其結果,會有使過去材料之配向感度變得極小之問題。 When an alignment material is formed using acrylic resin or the like having a photodimerization site such as cinnamyl acetyl group on the side chain, and the polymerizable liquid crystal is aligned, the acrylic resin or the like is photo-crosslinked by photodimerization reaction. Furthermore, it is necessary to perform polarized light irradiation with a large exposure amount until the resistance to the polymerizable liquid crystal solution is exhibited. In order to align the liquid crystal of the LCD panel, usually only The surface of the photo-alignment alignment material may be subjected to a dimerization reaction. However, when using the above-mentioned acrylic resin and other past materials to make the alignment material exhibit solvent resistance, it is necessary to react to the inside of the alignment material, and more exposure is required. As a result, there is a problem that the alignment sensitivity of the past material becomes extremely small.

又,為了使上述過去材料的樹脂展現此種耐溶劑性,添加交聯劑之技術為已知。然而,已知利用交聯劑進行熱硬化反應後,在形成的塗膜之內部會形成3次元構造,使光反應性下降。亦即,配向感度會大幅下降,即使於過去之材料中添加交聯劑來使用,仍無法獲得期望之效果。 In addition, in order to make the resins of the above-mentioned conventional materials exhibit such solvent resistance, a technique of adding a crosslinking agent is known. However, it is known that after a thermosetting reaction using a cross-linking agent, a three-dimensional structure is formed inside the formed coating film, which reduces the photoreactivity. That is, the alignment sensitivity will be greatly reduced. Even if the cross-linking agent is added to the material in the past to use it, the desired effect cannot be obtained.

基於上述,要求提高配向材之配向感度,且可降低偏光UV曝光量之光配向技術,與該配向材之形成所用之硬化膜形成組成物。而且,要求可高效率地提供圖型化相位差材之技術。 Based on the above, it is required to improve the alignment sensitivity of the alignment material, and to reduce the polarized UV exposure of light alignment technology, and the alignment material used to form a cured film forming composition. Furthermore, a technology that can efficiently provide patterned phase difference materials is required.

又,使用光配向技術製造3D顯示器之圖型化相位差材時,過去係在無鹼玻璃基板上形成。然而,近年來因應製造成本下降之要求,而要求在鹼玻璃等之便宜基材上生產。 In addition, when manufacturing a patterned phase difference material for a 3D display using optical alignment technology, it was formed on an alkali-free glass substrate in the past. However, in recent years, it has been required to produce on cheap base materials such as alkali glass in response to the demand for a reduction in manufacturing costs.

然而,如上述由過去之材料形成之光配向膜因鹼玻璃中之Na成分之影響而無法良好地配向。 However, as described above, the light alignment film formed from the materials in the past cannot be well aligned due to the influence of the Na component in the alkali glass.

因此,要求可形成密著性優異且即使在鹼玻璃上亦為高信賴之相位差材、可適用於光配向技術之配向材、與用於形成此配向材之硬化膜形成組成物。 Therefore, it is required to form a phase difference material having excellent adhesion and high reliability even on alkali glass, an alignment material applicable to optical alignment technology, and a cured film forming composition for forming the alignment material.

本發明係基於以上見解或檢討結果而完成 者。亦即,本發明之目的係提供一種用於提供具有優異之光反應效率而且具備耐溶劑性,即使在鹼玻璃上仍可以高感度使聚合性液晶配向之配向材的硬化膜形成組成物。 The present invention is completed based on the above insights or review results By. That is, an object of the present invention is to provide a cured film forming composition for an alignment material that has excellent light reaction efficiency and has solvent resistance, and can be used to align polymerizable liquid crystals with high sensitivity even on alkali glass.

而且,本發明之另一目的係提供一種由該硬化膜形成組成物所得之具有優異之光反應效果而且具備耐溶劑性,即使在鹼玻璃上仍可以高感度使聚合性液晶配向之配向材與使用該配向材形成之相位差材料。 Moreover, another object of the present invention is to provide an alignment material obtained from the cured film-forming composition which has an excellent photoreaction effect and has solvent resistance and can align polymerizable liquid crystals with high sensitivity even on alkali glass The phase difference material formed using this alignment material.

本發明之其他目的及優點由以下之記載可明瞭。 Other objects and advantages of the present invention will be apparent from the following description.

本發明之第1樣態為一種硬化膜形成組成物,其特徵係含有(A)具有光配向性基與由羥基、羧基及胺基選出之任一個取代基之化合物、(B)具有由羥基、羧基及胺基選出之一種或兩種以上之取代基之親水性聚合物、以及(C)具有胺基之烷氧基矽烷化合物。 The first aspect of the present invention is a cured film forming composition, which is characterized by containing (A) a compound having a photo-alignment group and any substituent selected from a hydroxyl group, a carboxyl group and an amine group, and (B) having a hydroxyl group , A hydrophilic polymer with one or two or more substituents selected from carboxyl group and amine group, and (C) an alkoxysilane compound having an amine group.

本發明之第1樣態中,(A)成分之光配向性基較好為進行光二聚化或光異構化之構造的官能基。 In the first aspect of the present invention, the photo-alignment group of the component (A) is preferably a functional group having a structure that undergoes photo-dimerization or photo-isomerization.

本發明之第1樣態中,(A)成分之光配向性基較好為桂皮醯基。 In the first aspect of the present invention, the photo-alignment group of the component (A) is preferably a cassia acyl group.

本發明之第1樣態中,(A)成分之光配向性基較好為偶氮苯構造之基。 In the first aspect of the present invention, the photo-alignment group of component (A) is preferably a group of azobenzene structure.

本發明之第1樣態中,(B)成分較好為由聚醚多元醇、聚酯多元醇、聚碳酸酯多元醇及聚己內酯多元醇所組成群組選出之至少一種聚合物。 In the first aspect of the present invention, the component (B) is preferably at least one polymer selected from the group consisting of polyether polyol, polyester polyol, polycarbonate polyol and polycaprolactone polyol.

本發明之第1樣態中,(B)成分較好為纖維素或其衍生物。 In the first aspect of the present invention, the component (B) is preferably cellulose or a derivative thereof.

本發明之第1樣態中,(B)成分較好為具有聚乙二醇酯基及碳原子數2~5之羥基烷酯基中之至少一者,與羧基及酚性羥基中之至少一者之丙烯酸系聚合物。 In the first aspect of the present invention, the component (B) preferably has at least one of a polyethylene glycol ester group and a hydroxyalkyl ester group having 2 to 5 carbon atoms, and at least one of a carboxyl group and a phenolic hydroxyl group One is acrylic polymer.

本發明之第1樣態中,(B)成分較好為藉由使包含具有聚乙二醇酯基之單體及具有碳原子數2~5之羥基烷酯基之單體中之至少一者,與具有羧基之單體及具有酚性羥基之單體中之至少一者的單體之聚合反應獲得之丙烯酸共聚物。 In the first aspect of the present invention, component (B) is preferably composed of at least one of a monomer having a polyethylene glycol ester group and a monomer having a hydroxyalkyl ester group having 2 to 5 carbon atoms An acrylic copolymer obtained by the polymerization reaction of a monomer having at least one of a monomer having a carboxyl group and a monomer having a phenolic hydroxyl group.

本發明之第1樣態中,(B)成分較好為環糊精或其衍生物。 In the first aspect of the present invention, the component (B) is preferably cyclodextrin or a derivative thereof.

本發明之第1樣態中,(A)成分與(B)成分之比率以質量比計,較好為5:95至60:40。 In the first aspect of the present invention, the ratio of the component (A) to the component (B) is preferably 5:95 to 60:40 in terms of mass ratio.

本發明之第1樣態中,基於(A)成分及(B)成分之合計量100質量份,較好含10質量份至100質量份之(C)成分。 In the first aspect of the present invention, 100 parts by mass based on the total of the component (A) and the component (B), preferably 10 to 100 parts by mass of the component (C).

本發明之第2樣態係關於一種配向材,其特徵係使用本發明之第1樣態之熱硬化膜形成組成物所得。 The second aspect of the present invention relates to an alignment material characterized by using the thermosetting film-forming composition of the first aspect of the present invention.

本發明之第3樣態係關於一種相位差材,其特徵係使用由本發明之第1樣態之硬化膜形成組成物所得 之硬化膜而形成。 The third aspect of the present invention relates to a phase difference material characterized by using the cured film forming composition of the first aspect of the present invention Formed by a hardened film.

依據本發明之第1樣態,可提供一種用於提供具有優異之光反應效率且具備耐溶劑性,即使在鹼玻璃上仍可以高感度使聚合性液晶配向之配向材之硬化膜形成組成物。 According to the first aspect of the present invention, it is possible to provide a cured film forming composition for an alignment material having excellent photoreaction efficiency and solvent resistance, which can align polymerizable liquid crystal with high sensitivity even on alkali glass .

依據本發明之第2樣態可提供一種具備優異之光反應效率與耐溶劑性,且即使在鹼玻璃上仍可以高感度使聚合性液晶配向之配向材。 According to the second aspect of the present invention, an alignment material having excellent light reaction efficiency and solvent resistance, and capable of aligning polymerizable liquid crystal with high sensitivity even on alkali glass can be provided.

依據本發明之第3樣態可提供一種即使在鹼玻璃上仍可高效率地形成之可光學圖型化之相位差材。 According to the third aspect of the present invention, it is possible to provide an optically patternable retardation material that can be efficiently formed even on alkali glass.

〈硬化膜形成組成物〉 <Hardened film forming composition>

本實施形態之硬化膜形成組成物含有(A)成分的低分子之光配向成分,(B)成分的親水性聚合物,與(C)成分的具有胺基之烷氧基矽烷化合物。而且,本實施形態之硬化膜形成組成物除(A)成分、(B)成分、(C)成分以外,只要不損及本發明之效果,亦可含有其他添加劑。 The cured film forming composition of this embodiment contains a low-molecular light alignment component of component (A), a hydrophilic polymer of component (B), and an alkoxysilane compound having an amine group of component (C). Furthermore, the cured film forming composition of the present embodiment may contain other additives in addition to the components (A), (B), and (C) as long as the effects of the present invention are not impaired.

以下說明各成分之細節。 The details of each component are explained below.

〈(A)成分〉 <(A) ingredient>

本實施形態之硬化膜形成組成物中含有之(A)成分為上述之低分子之光配向成分。 The component (A) contained in the cured film forming composition of this embodiment is the above-mentioned low molecular light alignment component.

而且,(A)成分的低分子光配向成分可為具有光配向性基與由羥基、羧基及胺基選出之任一個取代基之化合物。具有光配向性基與由羥基、羧基及胺基選出之任一個取代基之化合物係如上述,光反應性基構成光反應成分中之疏水性之光反應部,且羥基等構成親水性之熱反應部。 Furthermore, the low-molecular photo-alignment component of the component (A) may be a compound having a photo-alignment group and any substituent selected from the group consisting of a hydroxyl group, a carboxyl group, and an amine group. The compound having a photo-alignment group and any substituent selected from the group consisting of a hydroxyl group, a carboxyl group and an amine group is as described above. Reaction Department.

又,本發明中,光配向性基意指進行光二聚化或光異構化之構造部位。 In addition, in the present invention, the photo-alignment group means a structural part that undergoes photo-dimerization or photo-isomerization.

所謂進行光二聚化之構造部位為藉由光照射形成二聚物之部位,其具體例列舉為桂皮醯基、查爾酮基、香豆素基、蒽基等。該等中以在可見光區域中具有高透明性及光二聚化反應性之桂皮醯基較佳。另外,所謂進行光異構化之構造部位係指藉由光照射使順式體與反式體互變之構造部位,其具體例列舉為由偶氮苯構造、二苯乙烯構造等所成之部位。該等中就反應性高而言以偶氮苯構造較佳。具有光配向性基與羥基之化合物係例如以下述式表示。 The structural part that performs photodimerization is a part where a dimer is formed by light irradiation, and specific examples thereof include cassia acetyl, chalcone, coumarin, and anthracenyl. Among these, a cassia acetyl group having high transparency and photodimerization reactivity in the visible light region is preferable. In addition, the structural site that undergoes photoisomerization refers to a structural site where the cis-form and the trans-form are interconverted by light irradiation, and specific examples thereof include an azobenzene structure and a stilbene structure. Location. Among these, the azobenzene structure is preferable in terms of high reactivity. The compound having a photo-alignment group and a hydroxyl group is represented by the following formula, for example.

上述式中,X1表示單鍵、或表示透過共價鍵、醚鍵、酯鍵、醯胺鍵、胺基鍵或脲鍵鍵結之碳原子數1~18之伸烷基、伸苯基、伸聯苯基或伸環己基。此時,伸烷基、伸苯基及伸聯苯基亦可由自鹵原子及氰基選出之相同或不同之1個以上之取代基取代。 In the above formula, X 1 represents a single bond, or represents an alkylene group having 1 to 18 carbon atoms or a phenyl group bonded by a covalent bond, an ether bond, an ester bond, an amide bond, an amino bond, or a urea bond , Bibiphenyl or cyclohexyl. At this time, the alkylene group, the phenylene group and the biphenylene group may be substituted by one or more substituents selected from the same or different from the halogen atom and the cyano group.

上述式中,X2表示氫原子、氰基、硝基、碳原子數1~18之烷基、苯基、聯苯基或環烷基。此時,碳原子數1~18之烷基、苯基、聯苯基及環己基亦可經由共價鍵、醚鍵、酯鍵、醯胺鍵、胺基鍵或脲鍵鍵結,苯基及聯苯基亦可經鹵原子及胺基之任一者取代。 In the above formula, X 2 represents a hydrogen atom, a cyano group, a nitro group, an alkyl group having 1 to 18 carbon atoms, a phenyl group, a biphenyl group, or a cycloalkyl group. At this time, the alkyl group having 1 to 18 carbon atoms, phenyl group, biphenyl group and cyclohexyl group may also be bonded via a covalent bond, ether bond, ester bond, amide bond, amine bond or urea bond, phenyl And biphenyl may also be substituted by any one of a halogen atom and an amine group.

上述式中,R1、R2、R3、R4、R5、R6、R7及R8各獨立表示氫原子、碳數1~4之烷基、碳數1~4之烷氧基、鹵原子、三氟甲基或氰基。 In the above formula, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 each independently represent a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, and an alkoxy group having 1 to 4 carbon atoms Group, halogen atom, trifluoromethyl group or cyano group.

(A)成分的具有光配向性基與羥基之化合物之具體例列舉為例如4-(8-羥基辛氧基)桂皮酸甲酯、4-(6-羥基己氧基)桂皮酸甲酯、4-(4-羥基丁氧基)桂皮酸甲酯、4-(3-羥基丙氧基)桂皮酸甲酯、4-(2-羥基乙 氧基)桂皮酸甲酯、4-羥基甲氧基桂皮酸甲酯、4-羥基桂皮酸甲酯、4-(8-羥基辛氧基)桂皮酸乙酯、4-(6-羥基己氧基)桂皮酸乙酯、4-(4-羥基丁氧基)桂皮酸乙酯、4-(3-羥基丙氧基)桂皮酸乙酯、4-(2-羥基乙氧基)桂皮酸乙酯、4-羥基甲氧基桂皮酸乙酯、4-羥基桂皮酸乙酯、4-(8-羥基辛氧基)桂皮酸苯酯、4-(6-羥基己氧基)桂皮酸苯酯、4-(4-羥基丁氧基)桂皮酸苯酯、4-(3-羥基丙氧基)桂皮酸苯酯、4-(2-羥基乙氧基)桂皮酸苯酯、4-羥基甲氧基桂皮酸苯酯、4-羥基桂皮酸苯酯、4-(8-羥基辛氧基)桂皮酸聯苯酯、4-(6-羥基己氧基)桂皮酸聯苯酯、4-(4-羥基丁氧基)桂皮酸聯苯酯、4-(3-羥基丙氧基)桂皮酸聯苯酯、4-(2-羥基乙氧基)桂皮酸聯苯酯、4-羥基甲氧基桂皮酸聯苯酯、4-羥基桂皮酸聯苯酯、桂皮酸8-羥基辛酯、桂皮酸6-羥基己酯、桂皮酸4-羥基丁酯、桂皮酸3-羥基丙酯、桂皮酸2-羥基乙酯、桂皮酸羥基甲酯、4-(8-羥基辛氧基)偶氮苯、4-(6-羥基己氧基)偶氮苯、4-(4-羥基丁氧基)偶氮苯、4-(3-羥基丙氧基)偶氮苯、4-(2-羥基乙氧基)偶氮苯、4-羥基甲氧基偶氮苯、4-羥基偶氮苯、4-(8-羥基辛氧基)查爾酮、4-(6-羥基己氧基)查爾酮、4-(4-羥基丁氧基)查爾酮、4-(3-羥基丙氧基)查爾酮、4-(2-羥基乙氧基)查爾酮、4-羥基甲氧基查爾酮、4-羥基查爾酮、4’-(8-羥基辛氧基)查爾酮、4’-(6-羥基己氧基)查爾酮、4’-(4-羥基丁氧基)查爾酮、4’-(3-羥基丙氧 基)查爾酮、4’-(2-羥基乙氧基)查爾酮、4’-羥基甲氧基查爾酮、4’-羥基查爾酮、7-(8-羥基辛氧基)香豆素、7-(6-羥基己氧基)香豆素、7-(4-羥基丁氧基)香豆素、7-(3-羥基丙氧基)香豆素、7-(2-羥基乙氧基)香豆素、7-羥基甲氧基香豆素、7-羥基香豆素、6-羥基辛氧基香豆素、6-羥基己氧基香豆素、6-(4-羥基丁氧基)香豆素、6-(3-羥基丙氧基)香豆素、6-(2-羥基乙氧基)香豆素、6-羥基甲氧基香豆素、6-羥基香豆素。 (A) Specific examples of the compound having a photo-alignment group and a hydroxyl group of the component are, for example, methyl 4- (8-hydroxyoctyloxy) cinnamate, methyl 4- (6-hydroxyhexyloxy) cinnamate, 4- (4-Hydroxybutoxy) cinnamic acid methyl ester, 4- (3-hydroxypropoxy) cinnamic acid methyl ester, 4- (2-hydroxyethyl Oxy) cinnamic acid methyl ester, 4-hydroxymethoxy cinnamic acid methyl ester, 4-hydroxy cinnamic acid methyl ester, 4- (8-hydroxyoctyloxy) ethyl cinnamic acid ethyl ester, 4- (6-hydroxyhexyloxy) Ethyl) cinnamic acid ethyl ester, 4- (4-hydroxybutoxy) ethyl cinnamic acid ethyl ester, 4- (3-hydroxypropoxy) ethyl cinnamic acid ethyl ester, 4- (2-hydroxyethoxy) ethyl cinnamic acid ethyl Ester, 4-hydroxymethoxycinnamic acid ethyl ester, 4-hydroxycinnamic acid ethyl ester, 4- (8-hydroxyoctyloxy) cinnamic acid phenyl ester, 4- (6-hydroxyhexyloxy) cinnamic acid phenyl ester , 4- (4-hydroxybutoxy) cinnamic acid phenyl ester, 4- (3-hydroxypropoxy) cinnamic acid phenyl ester, 4- (2-hydroxyethoxy) cinnamic acid phenyl ester, 4-hydroxymethyl Oxycinnamic acid phenyl ester, 4-hydroxycinnamic acid phenyl ester, 4- (8-hydroxyoctyloxy) cinnamic acid biphenyl ester, 4- (6-hydroxyhexyloxy) cinnamic acid biphenyl ester, 4- ( 4-hydroxybutoxy) cinnamic acid biphenyl ester, 4- (3-hydroxypropoxy) cinnamic acid biphenyl ester, 4- (2-hydroxyethoxy) cinnamic acid biphenyl ester, 4-hydroxymethoxy Cinnamic acid biphenyl ester, 4-hydroxycinnamic acid biphenyl ester, cinnamic acid 8-hydroxyoctyl ester, cinnamic acid 6-hydroxyhexyl, cinnamic acid 4-hydroxybutyl ester, cinnamic acid 3-hydroxypropyl ester, cinnamic acid 3-hydroxypropyl ester, cinnamic acid 2-hydroxyethyl , Hydroxymethyl cinnamate, 4- (8-hydroxyoctyloxy) azobenzene, 4- (6-hydroxyhexyloxy) azobenzene, 4- (4-hydroxybutoxy) azobenzene, 4 -(3-hydroxypropoxy) azobenzene, 4- (2-hydroxyethoxy) azobenzene, 4-hydroxymethoxyazobenzene, 4-hydroxyazobenzene, 4- (8-hydroxyl Octyloxy) chalcone, 4- (6-hydroxyhexyloxy) chalcone, 4- (4-hydroxybutoxy) chalcone, 4- (3-hydroxypropoxy) chalcone, 4- (2-hydroxyethoxy) chalcone, 4-hydroxymethoxychalcone, 4-hydroxychalcone, 4 '-(8-hydroxyoctyloxy) chalcone, 4'-( 6-hydroxyhexyloxy) chalcone, 4 '-(4-hydroxybutoxy) chalcone, 4'-(3-hydroxypropoxy Base) chalcone, 4 '-(2-hydroxyethoxy) chalcone, 4'-hydroxymethoxychalcone, 4'-hydroxychalcone, 7- (8-hydroxyoctyloxy) Coumarin, 7- (6-Hydroxyhexyloxy) Coumarin, 7- (4-Hydroxybutoxy) Coumarin, 7- (3-Hydroxypropoxy) Coumarin, 7- (2 -Hydroxyethoxy) coumarin, 7-hydroxymethoxycoumarin, 7-hydroxycoumarin, 6-hydroxyoctoxycoumarin, 6-hydroxyhexoxycoumarin, 6- ( 4-hydroxybutoxy) coumarin, 6- (3-hydroxypropoxy) coumarin, 6- (2-hydroxyethoxy) coumarin, 6-hydroxymethoxy coumarin, 6 -Hydroxycoumarin.

具有光配向性基與羧基之化合物之具體例列舉為桂皮酸、阿魏酸(ferulic acid)、4-硝基桂皮酸、4-甲氧基桂皮酸、3,4-二甲氧基桂皮酸、香豆素-3-羧酸、4-(N,N-二甲基胺基)桂皮酸等。 Specific examples of the compound having a photo-alignment group and a carboxyl group include cinnamic acid, ferulic acid, 4-nitrocinnamic acid, 4-methoxycinnamic acid, 3,4-dimethoxycinnamic acid , Coumarin-3-carboxylic acid, 4- (N, N-dimethylamino) cinnamic acid, etc.

具有光配向性基與胺基之化合物之具體例列舉為甲基-4-胺基桂皮酸、乙基-4-胺基桂皮酸、甲基-3-胺基桂皮酸、乙基-3-胺基桂皮酸等。 Specific examples of the compound having a photo-alignment group and an amine group are methyl-4-aminocinnamic acid, ethyl-4-aminocinnamic acid, methyl-3-aminocinnamic acid, ethyl-3- Aminocinnamic acid, etc.

(A)成分的低分子光配向成分可列舉為以上之具體例,但並不限於該等。 (A) The low-molecular-weight photo-alignment component of a component can be mentioned as the above specific example, but it is not limited to these.

另外,(A)成分的光配向成分為具有光配向性基與羥基之化合物時,(A)成分可使用分子內具有2個以上之光配向性基及/或2個以上羥基之化合物。具體而言,(A)成分可為分子內具有1個羥基與2個以上光配向性基之化合物、或分子內具有1個光配向性基與2個以上羥基之化合物、或分子內分別具有2個以上之光配向性基與羥基之化合物。例如,關於分子內分別具有2個以 上之光配向性基與羥基之化合物,作為其一例,可列出以下述式表示之化合物。 In addition, when the photo-alignment component of the component (A) is a compound having a photo-alignment group and a hydroxyl group, a compound having two or more photo-alignment groups and / or two or more hydroxyl groups in the molecule can be used for the (A) component. Specifically, the component (A) may be a compound having one hydroxyl group and two or more photo-alignment groups in the molecule, or a compound having one light alignment group and two or more hydroxyl groups in the molecule, or respectively having in the molecule Compounds with more than two photoalignment groups and hydroxyl groups. For example, there are two The compound of the photo-alignment group and the hydroxyl group on the above can be listed as an example of the compound represented by the following formula.

藉由適當選擇此種化合物,可控制提高(A)成分之光配向成分之分子量。結果,如後述,(A)成分的光配向成分及(B)成分的聚合物與(C)成分的交聯劑進行熱反應時,可抑制(A)成分的光配向成分昇華。而且,本實施形態之硬化膜形成組成物可形成光反應效率高之配向材作為硬化膜。 By appropriately selecting such a compound, the molecular weight of the photo-alignment component of (A) component can be controlled to increase. As a result, as will be described later, when the optical alignment component of the component (A) and the polymer of the component (B) and the crosslinking agent of the component (C) thermally react, the sublimation of the optical alignment component of the component (A) can be suppressed. Furthermore, the cured film forming composition of this embodiment can form an alignment material having a high photoreaction efficiency as a cured film.

又,本實施形態之硬化膜形成組成物中之(A)成分的化合物亦可為具有光配向性基與由羥基、羧基及胺基選出之任一個基之取代基之複數種化合物之混合物。 In addition, the compound of the component (A) in the cured film forming composition of this embodiment may be a mixture of a plurality of compounds having a photo-alignment group and a substituent selected from any group selected from a hydroxyl group, a carboxyl group, and an amine group.

〈(B)成分〉 <(B) ingredient>

本實施形態之硬化膜形成組成物中含有之(B)成分為親水性之聚合物。 The component (B) contained in the cured film forming composition of this embodiment is a hydrophilic polymer.

而且,(B)成分之聚合物可為具有由羥基、羧基及胺基選出之1種或2種以上之取代基之聚合物(以下亦稱為特定聚合物)。 In addition, the polymer of the component (B) may be a polymer having one or more substituents selected from a hydroxyl group, a carboxyl group, and an amine group (hereinafter also referred to as a specific polymer).

本實施形態之硬化膜形成組成物中,作為(B)成分的特定聚合物,係以比(A)成分更具親水性地具備高親水性之高親水性聚合物的選擇為佳。因此,特定聚合物較好為具有羥基或羧基或胺基等親水性基之聚合物,具體而言,較好為具有由羥基、羧基及胺基選出之1種或2種以上之取代基之聚合物。 In the cured film-forming composition of the present embodiment, the specific polymer as the component (B) is preferably selected from a highly hydrophilic polymer having higher hydrophilicity than the component (A). Therefore, the specific polymer is preferably a polymer having a hydrophilic group such as a hydroxyl group, a carboxyl group, or an amine group, and specifically, it is preferably one having one or more substituents selected from a hydroxyl group, a carboxyl group, and an amine group. polymer.

(B)成分的聚合物列舉為例如丙烯酸聚合物、聚醯胺酸、聚醯亞胺、聚乙烯醇、聚酯、聚酯聚羧酸、聚醚多元醇、聚酯多元醇、聚碳酸酯多元醇、聚己內酯多元醇、聚伸烷基亞胺、聚烯丙基胺、纖維素類(纖維素或其衍生物)、酚酚醛清漆樹脂、三聚氰胺甲醛樹脂等之具有直鏈構造或分支構造之聚合物、環糊精類等之環狀聚合物等。 The polymer of (B) component is exemplified by acrylic polymer, polyamic acid, polyimide, polyvinyl alcohol, polyester, polyester polycarboxylic acid, polyether polyol, polyester polyol, polycarbonate Polyols, polycaprolactone polyols, polyalkylene imines, polyallylamines, celluloses (cellulose or its derivatives), phenol novolak resins, melamine formaldehyde resins, etc. have a linear structure or Cyclic polymers such as branched polymers, cyclodextrins, etc.

其中,作為丙烯酸聚合物較適用使丙烯酸酯、甲基丙烯酸酯、苯乙烯等之具有不飽和雙鍵之單體聚合而得之聚合物。 Among them, as the acrylic polymer, a polymer obtained by polymerizing monomers having unsaturated double bonds such as acrylate, methacrylate, and styrene is more suitable.

(B)成分的特定聚合物較好為.羥基烷基環糊精類,.纖維素類,.具有聚乙二醇酯基及碳原子數2~5之羥基烷酯基中之至少一者,與羧基及酚性羥基中之至少一者之丙烯酸聚合物,.側鏈上具有胺基烷基之丙烯酸聚合物,.聚醚多元醇, .聚酯多元醇,.聚碳酸酯多元醇,及.聚己內酯多元醇。 (B) The specific polymer of the component is preferably. Hydroxyalkyl cyclodextrins. Cellulose, An acrylic polymer having at least one of a polyethylene glycol ester group and a hydroxyalkyl ester group having 2 to 5 carbon atoms, and at least one of a carboxyl group and a phenolic hydroxyl group. Acrylic polymers with aminoalkyl groups on the side chain. Polyether polyol, . Polyester polyol. Polycarbonate polyol, and. Polycaprolactone polyol.

(B)成分的特定聚合物之較佳一例之具有聚乙二醇酯基及碳原子數2~5之羥基烷酯基中之至少一者與羧基及酚性羥基中之至少一者之丙烯酸聚合物只要是具有該構造之丙烯酸聚合物即可,關於構成丙烯酸聚合物之高分子主鏈之骨架及側鏈之種類等並未特別限制。 (B) A preferred example of the specific polymer of the component is acrylic acid having at least one of a polyethylene glycol ester group and a hydroxyalkyl ester group having 2 to 5 carbon atoms, and at least one of a carboxyl group and a phenolic hydroxyl group The polymer may be any acrylic polymer having such a structure, and there is no particular limitation on the type of the backbone and side chain of the polymer main chain constituting the acrylic polymer.

至於具有聚乙二醇酯基及碳原子數2~5之羥基烷酯基中之至少一者之構造單位,較佳之構造單位係以下述式[B1]表示。 As for the structural unit having at least one of a polyethylene glycol ester group and a hydroxyalkyl ester group having 2 to 5 carbon atoms, the preferred structural unit is represented by the following formula [B1].

至於具有羧基及酚性羥基中之至少一者之構造單位,較佳之構造單位係以下述式[B2]表示。 As for the structural unit having at least one of a carboxyl group and a phenolic hydroxyl group, a preferred structural unit is represented by the following formula [B2].

上述式[B1]及[B2]中,X3及X4各獨立表示氫原子或甲基,Y1表示H-(OCH2CH2)n-基(此處,n之值為2~50,較好為2~10)或碳原子數2~5之羥基烷基,Y2表示羧基或酚性羥基。 In the above formulas [B1] and [B2], X 3 and X 4 each independently represent a hydrogen atom or a methyl group, and Y 1 represents an H- (OCH 2 CH 2 ) n -group (here, the value of n is 2 to 50 , Preferably 2 to 10) or a hydroxyalkyl group having 2 to 5 carbon atoms, and Y 2 represents a carboxyl group or a phenolic hydroxyl group.

(B)成分之例的丙烯酸聚合物之重量平均分 子量較好為3,000至200,000,更好為4,000至150,000,又更好為5,000至100,000。重量平均分子量超過200,000而過大者時,對溶劑之溶解性低且會有處理性降低之情況,重量平均分子量未達3,000而過小者時,熱硬化時之硬化不足而會有耐溶劑性及耐熱性降低之情況。又,重量平均分子量係以凝膠滲透層析儀(GPC),使用聚苯乙烯作為標準資料所得之值。以下,在本說明書中亦相同。 (B) Weight average score of acrylic polymer as an example of component The sub-weight is preferably 3,000 to 200,000, more preferably 4,000 to 150,000, and still more preferably 5,000 to 100,000. When the weight-average molecular weight exceeds 200,000, if it is too large, the solubility to the solvent will be low and there will be a decrease in handleability. If the weight-average molecular weight is less than 3,000, if it is too small, the curing will be insufficient during thermal curing, resulting in solvent resistance and heat resistance. The situation of reduced sex. In addition, the weight average molecular weight is a value obtained by using gel permeation chromatography (GPC) using polystyrene as standard data. Hereinafter, the same applies to this specification.

至於(B)成分之例的丙烯酸聚合物之合成方法,使具有聚乙二醇酯基及碳原子數1~4之羥基烷酯基中之至少一者之單體(以下亦稱為b1單體)與具有羧基及酚性羥基中之至少一者之單體(以下亦稱為b2單體)共聚合之方法較簡單。 As for the synthesis method of the acrylic polymer as an example of the component (B), a monomer having at least one of a polyethylene glycol ester group and a hydroxyalkyl ester group having 1 to 4 carbon atoms (hereinafter also referred to as b1 monomer) The method of copolymerizing a monomer having at least one of a carboxyl group and a phenolic hydroxyl group (hereinafter also referred to as b2 monomer) is relatively simple.

上述具有聚乙二醇酯基之單體列舉為H-(OCH2CH2)n-OH之單丙烯酸酯或單甲基丙烯酸酯。n之值為2~50,較好為2~10。 The monomer having a polyethylene glycol ester group is exemplified by a monoacrylate or monomethacrylate of H- (OCH 2 CH 2 ) n -OH. The value of n is 2 to 50, preferably 2 to 10.

上述具有碳原子數2~5之羥基烷酯基之單體列舉為例如甲基丙烯酸2-羥基乙酯、丙烯酸2-羥基乙酯、甲基丙烯酸2-羥基丙酯、丙烯酸2-羥基丙酯、丙烯酸4-羥基丁酯、甲基丙烯酸4-羥基丁酯。 The monomer having a hydroxyalkyl ester group having 2 to 5 carbon atoms is exemplified by 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate, 2-hydroxypropyl methacrylate, 2-hydroxypropyl acrylate , 4-hydroxybutyl acrylate, 4-hydroxybutyl methacrylate.

上述具有羧基之單體列舉為例如丙烯酸、甲基丙烯酸、乙烯基苯甲酸。 Examples of the monomer having a carboxyl group include acrylic acid, methacrylic acid, and vinyl benzoic acid.

上述具有酚性羥基之單體列舉為例如對-羥基苯乙烯、間-羥基苯乙烯、鄰-羥基苯乙烯。 Examples of the monomer having a phenolic hydroxyl group include p-hydroxystyrene, m-hydroxystyrene, and o-hydroxystyrene.

又,本實施形態中,合成(B)成分之例的丙 烯酸聚合物時,只要不損及本發明之效果,可併用b1單體及b2單體以外之單體,具體而言為不具有羥基及羧基之任一者之單體。 In this embodiment, the example of the component (B) is synthesized. In the case of the enoic acid polymer, monomers other than b1 monomers and b2 monomers may be used in combination as long as the effects of the present invention are not impaired, specifically, monomers having neither a hydroxyl group nor a carboxyl group.

至於此種單體,列舉為例如丙烯酸甲酯、丙烯酸乙酯、丙烯酸丙酯、丙烯酸異丙酯、甲基丙烯酸丁酯、丙烯酸丁酯、丙烯酸異丁酯、丙烯酸第三丁酯等丙烯酸酯化合物,甲基丙烯酸甲酯、甲基丙烯酸乙酯、甲基丙烯酸丙酯、甲基丙烯酸異丙酯、甲基丙烯酸異丁酯、甲基丙烯酸第三丁酯等之甲基丙烯酸酯化合物,馬來醯亞胺、N-甲基馬來醯亞胺、N-苯基馬來醯亞胺及N-環己基馬來醯亞胺等之馬來醯亞胺化合物,丙烯醯亞胺化合物,丙烯腈,馬來酸酐,苯乙烯化合物及乙烯基化合物等。 Examples of such monomers include acrylate compounds such as methyl acrylate, ethyl acrylate, propyl acrylate, isopropyl acrylate, butyl methacrylate, butyl acrylate, isobutyl acrylate, and third butyl acrylate. , Methacrylate compounds such as methyl methacrylate, ethyl methacrylate, propyl methacrylate, isopropyl methacrylate, isobutyl methacrylate, tertiary butyl methacrylate, etc., Malay Maleimide compounds such as amideimine, N-methylmaleimide, N-phenylmaleimide and N-cyclohexylmaleimide, acrylonitrile compounds, acrylonitrile , Maleic anhydride, styrene compounds and vinyl compounds.

用於獲得(B)成分之例的丙烯酸聚合物所用之b1單體及b2單體之使用量,基於用於獲得(B)成分的丙烯酸聚合物所用之總單體合計量,b1單體較好為2莫耳%至95莫耳%,b2單體較好為5莫耳%至98莫耳%。 The amount of b1 monomer and b2 monomer used in the acrylic polymer used to obtain the component (B) is based on the total amount of monomers used in the acrylic polymer used to obtain the component (B). It is preferably 2 mol% to 95 mol%, and the b2 monomer is preferably 5 mol% to 98 mol%.

使用僅具有羧基之單體作為b2單體時,基於用於獲得(B)成分的丙烯酸聚合物所用之全部單體之合計量,較好b1單體為60莫耳%至95莫耳%,b2單體為5莫耳%至40莫耳%。 When a monomer having only a carboxyl group is used as the b2 monomer, based on the total amount of all monomers used for obtaining the acrylic polymer of the component (B), the b1 monomer is preferably 60 mol% to 95 mol%, The b2 monomer is 5 mol% to 40 mol%.

另一方面,使用僅具有酚性羥基之單體作為b2單體時,較好b1單體為2莫耳%至80莫耳%,b2單體為20莫耳%至98莫耳%。b2單體過少時液晶配向性易變得不 足,過大時與(A)成分之相溶性容易降低。 On the other hand, when a monomer having only a phenolic hydroxyl group is used as the b2 monomer, the b1 monomer is preferably 2 mol% to 80 mol%, and the b2 monomer is 20 mol% to 98 mol%. When the b2 monomer is too small, the liquid crystal alignment tends to be If it is too large, the compatibility with the component (A) tends to decrease.

獲得(B)成分之例的丙烯酸聚合物之方法並無特別限制,可例如在共存有b1單體與b2單體及視需要之b1單體及b2單體以外之單體及聚合起始劑等之溶劑中,在50℃至110℃之溫度下藉由聚合反應而得。此時,所用之溶劑只要是可使b1單體與b2單體、視需要使用之b1單體及b2單體以外之單體及聚合起始劑等溶解者即無特別限制。具體而言記載於後述之〈溶劑〉項中。 The method of obtaining the acrylic polymer of the component (B) is not particularly limited. For example, a monomer and a polymerization initiator other than the b1 monomer and the b2 monomer and optionally the b1 monomer and the b2 monomer may coexist. It is obtained by polymerization at a temperature of 50 ° C to 110 ° C in a solvent such as. In this case, the solvent used is not particularly limited as long as it can dissolve the b1 monomer and b2 monomer, monomers other than the b1 monomer and b2 monomer, and the polymerization initiator, etc., if necessary. Specifically, it is described in the "solvent" item described later.

(B)成分之特定聚合物之較佳例的側鏈上具有胺基烷基之丙烯酸聚合物列舉為例如使丙烯酸胺基乙酯、甲基丙烯酸胺基乙酯、丙烯酸胺基丙酯及甲基丙烯酸胺基丙酯等之胺基烷酯單體聚合者,或者使該胺基烷酯單體與由上述丙烯酸單體選出之1種或2種以上之單體共聚合者。 (B) A preferred example of the specific polymer of the component is an acrylic polymer having an amino alkyl group on the side chain. For example, amino ethyl acrylate, amino ethyl methacrylate, amino propyl acrylate, and methyl Those that polymerize aminoalkyl monomers such as aminopropyl acrylate, or copolymerize the aminoalkyl monomers with one or more monomers selected from the acrylic monomers.

以前述方法所得之(B)成分之例的丙烯酸聚合物通常為溶解於溶劑中之溶液狀態。 The acrylic polymer as an example of the component (B) obtained by the aforementioned method is usually in a solution state dissolved in a solvent.

且,可將以上述方法所得之(B)成分之例的丙烯酸聚合物之溶液倒入攪拌下之二乙醚或水等中再沉澱,過濾.洗淨生成之沉澱物後,在常壓或減壓下,進行常溫乾燥或加熱乾燥,可成為(B)成分之例的丙烯酸聚合物粉體。藉由前述操作,可去除與(B)成分之例的丙烯酸聚合物共存之聚合起始劑及未反應之單體,結果,獲得經純化之(B)成分之例的丙烯酸聚合物粉體。無法以一次操作充分純化時,只要使所得粉體再溶解於溶劑中, 重複進行上述操作即可。 And, can be obtained by the above method (B) component example of the acrylic polymer solution is poured into diethyl ether or water under stirring and then precipitated, filtered. After washing the generated precipitate, it is dried at room temperature or under normal pressure or reduced pressure to obtain an acrylic polymer powder as an example of the component (B). By the aforementioned operation, the polymerization initiator and unreacted monomer coexisting with the acrylic polymer of the component (B) component can be removed, and as a result, the acrylic polymer powder of the purified component (B) component can be obtained. When it is not possible to fully purify in one operation, as long as the resulting powder is redissolved in a solvent, Repeat the above operation.

(B)成分之特定聚合物之較佳一例的聚醚多元醇,舉例為於聚乙二醇、聚丙二醇、丙二醇與雙酚A、三乙二醇、山梨糖醇等多元醇上加成環氧丙烷或聚乙二醇、聚丙二醇等而成者。聚醚多元醇之具體例列舉為ADEKA製造之ADEKA POLYETHER P系列、G系列、EDP系列、BPX系列、FC系列、CM系列,日油製造之UNIOX(註冊商標)HC-40、HC-60、ST-30E、ST-40E、G-450、G-750、UNIOL(註冊商標)TG-330、TG-1000、TG-3000、TG-4000、HS-1600D、DA-400、DA-700、DB-400、NONION(註冊商標)LT-221、ST-221、OT-221等。 (B) A polyether polyol which is a preferred example of the specific polymer of the component is exemplified by the addition of polyglycol, polypropylene glycol, propylene glycol, and polyhydric alcohols such as bisphenol A, triethylene glycol, and sorbitol. Oxypropane, polyethylene glycol, polypropylene glycol, etc. Specific examples of polyether polyols include ADEKA POLYETHER P series, G series, EDP series, BPX series, FC series, CM series manufactured by ADEKA, UNIOX (registered trademark) HC-40, HC-60, ST manufactured by NOF Corporation -30E, ST-40E, G-450, G-750, UNIOL (registered trademark) TG-330, TG-1000, TG-3000, TG-4000, HS-1600D, DA-400, DA-700, DB- 400, NONION (registered trademark) LT-221, ST-221, OT-221, etc.

(B)成分之特定聚合物之較佳一例的聚酯多元醇,舉例為對己二酸、癸二酸、間苯二甲酸等多元羧酸反應乙二醇、丙二醇、丁二醇、聚乙二醇、聚丙二醇等二醇而成者。聚酯多元醇之具體例列舉為DIC製造之POLYLITE(註冊商標)OD-X-286、OD-X-102、OD-X-355、OD-X-2330、OD-X-240、OD-X-668、OD-X-2108、OD-X-2376、OD-X-2044、OD-X-688、OD-X-2068、OD-X-2547、OD-X-2420、OD-X-2523、OD-X-2555、OD-X-2560、KURARAY製造之POLYOL P-510、P-1010、P-2010、P-3010、P-4010、P-5010、P-6010、F-510、F-1010、F-2010、F-3010、P-1011、P-2011、P-2013、P-2030、N-2010、PNNA-2016、C-590、C-1050、C-2050、 C-2090、C-3090等。 (B) A preferred example of the specific polymer of the component is a polyester polyol, examples of which are reaction of polycarboxylic acids such as adipic acid, sebacic acid, and isophthalic acid with ethylene glycol, propylene glycol, butylene glycol, and polyethylene glycol. Diol, polypropylene glycol and other diols. Specific examples of polyester polyols are POLYLITE (registered trademark) manufactured by DIC OD-X-286, OD-X-102, OD-X-355, OD-X-2330, OD-X-240, OD-X -668, OD-X-2108, OD-X-2376, OD-X-2044, OD-X-688, OD-X-2068, OD-X-2547, OD-X-2420, OD-X-2523 , OD-X-2555, OD-X-2560, POLYOL P-510, P-1010, P-2010, P-3010, P-4010, P-5010, P-6010, F-510, F manufactured by KURARAY -1010, F-2010, F-3010, P-1011, P-2011, P-2013, P-2030, N-2010, PNNA-2016, C-590, C-1050, C-2050, C-2090, C-3090, etc.

(B)特定聚合物之較佳一例的聚己內酯多元醇,舉例為對三羥甲基丙烷或乙二醇等多元醇反應聚己內酯而成者。聚己內酯多元醇之具體例舉例為DIC製造之POLYLITE(註冊商標)OD-X-2155、OD-X-640、OD-X-2568,DAICEL化學製造之PLAXEL(註冊商標)205、L205AL、205U、208、210、212、L212AL、220、230、240、303、305、308、312、320等。 (B) The polycaprolactone polyol which is a preferable example of the specific polymer is exemplified by reacting polycaprolactone with a polyhydric alcohol such as trimethylolpropane or ethylene glycol. Specific examples of polycaprolactone polyols are POLYITE (registered trademark) OD-X-2155, OD-X-640, OD-X-2568 manufactured by DIC, PLAXEL (registered trademark) 205, L205AL manufactured by DAICEL Chemicals, 205U, 208, 210, 212, L212AL, 220, 230, 240, 303, 305, 308, 312, 320, etc.

(B)成分之特定聚合物之較佳一例的聚碳酸酯多元醇,舉例為對三羥甲基丙烷或乙二醇等多元醇反應聚碳酸酯而成者。聚碳酸酯多元醇之具體例列舉為DAICEL化學製造之PLAXEL(註冊商標)CD205、CD205PL、CD210、CD220等。 (B) A polycarbonate polyol which is a preferred example of the specific polymer of the component is exemplified by reacting polycarbonate with a polyol such as trimethylolpropane or ethylene glycol. Specific examples of polycarbonate polyols include PLAXEL (registered trademark) CD205, CD205PL, CD210, CD220, etc. manufactured by DAICEL Chemicals.

(B)成分之特定聚合物之較佳一例的纖維素列舉為羥基乙基纖維素、羥基丙基纖維素等羥基烷基纖維素類,羥基乙基甲基纖維素、羥基丙基甲基纖維素、羥基乙基乙基纖維素等羥基烷基烷基纖維素類及纖維素等,較好為例如羥基乙基纖維素、羥基丙基纖維素等羥基烷基纖維素類。 (B) Preferred examples of the specific polymer of the component include hydroxyalkyl celluloses such as hydroxyethyl cellulose and hydroxypropyl cellulose, hydroxyethyl methyl cellulose and hydroxypropyl methyl fiber Hydroxyalkylalkyl celluloses such as cellulose, hydroxyethylethyl cellulose, cellulose and the like are preferably hydroxyalkyl celluloses such as hydroxyethyl cellulose and hydroxypropyl cellulose.

(B)成分之特定聚合物之較佳一例的環糊精舉例為α-環糊精、β-環糊精及γ-環糊精等環糊精、甲基-α-環糊精、甲基-β-環糊精及甲基-γ-環糊精等之甲基化環糊精、羥基甲基-α-環糊精、羥基甲基-β-環糊精、羥基甲基-γ-環糊精、2-羥基乙基-α-環糊精、2-羥基乙基-β-環糊 精、2-羥基乙基-γ-環糊精、2-羥基丙基-α-環糊精、2-羥基丙基-β-環糊精、2-羥基丙基-γ-環糊精、3-羥基丙基-α-環糊精、3-羥基丙基-β-環糊精、3-羥基丙基-γ-環糊精、2,3-二羥基丙基-α-環糊精、2,3-二羥基丙基-β-環糊精、2,3-二羥基丙基-γ-環糊精等羥基烷基環糊精等。 (B) Preferred examples of the specific polymer of the component are cyclodextrins such as α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin, methyl-α-cyclodextrin, and alpha -Β-cyclodextrin, methyl-γ-cyclodextrin and other methylated cyclodextrin, hydroxymethyl-α-cyclodextrin, hydroxymethyl-β-cyclodextrin, hydroxymethyl-γ -Cyclodextrin, 2-hydroxyethyl-α-cyclodextrin, 2-hydroxyethyl-β-cyclodextrin Sperm, 2-hydroxyethyl-γ-cyclodextrin, 2-hydroxypropyl-α-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin, 2-hydroxypropyl-γ-cyclodextrin, 3-hydroxypropyl-α-cyclodextrin, 3-hydroxypropyl-β-cyclodextrin, 3-hydroxypropyl-γ-cyclodextrin, 2,3-dihydroxypropyl-α-cyclodextrin , 2,3-dihydroxypropyl-β-cyclodextrin, 2,3-dihydroxypropyl-γ-cyclodextrin and other hydroxyalkyl cyclodextrins.

(B)成分之特定聚合物之較佳一例的三聚氰酸甲醛樹脂係使三聚氰胺與甲醛聚縮合所得之樹脂且以下述式表示。 (B) The cyanuric formaldehyde resin, which is a preferred example of the specific polymer of the component, is a resin obtained by polycondensation of melamine and formaldehyde and is represented by the following formula.

上述式中,R表示氫原子或碳原子數1~4之烷基。 In the above formula, R represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.

(B)成分之三聚氰胺甲醛樹脂,就儲存安定性之觀點而言,較好為使三聚氰胺與甲醛聚縮合時生成之羥甲基經烷基化。 (B) The melamine formaldehyde resin of the component is preferably an alkylated methylol group formed during the polycondensation of melamine and formaldehyde from the viewpoint of storage stability.

獲得(B)成分之三聚氰胺甲醛樹脂之方法並無特別限制,但一般為混合三聚氰胺與甲醛,使用碳酸鈉或氨等成為弱鹼性後在60-100℃下加熱而合成。進而可藉由與醇反應而使羥甲基烷氧基化。 The method of obtaining the melamine formaldehyde resin of the component (B) is not particularly limited, but generally it is synthesized by mixing melamine and formaldehyde, using sodium carbonate or ammonia, etc. to become weakly alkaline and heating at 60-100 ° C. Furthermore, hydroxymethyl can be alkoxylated by reaction with alcohol.

(B)成分之三聚氰胺甲醛樹脂之重量平均分子量較好為250至5,000,更好為300至4,000,又更好為350至3,500。重量平均分子量超過5,000而過大時,會有 對溶劑之溶解性下降且處理性降低之情況,重量平均分子量未達250而過小時,熱硬化時硬化不足而有耐溶劑性及耐熱性降低之情況。 (B) The component melamine formaldehyde resin has a weight average molecular weight of preferably 250 to 5,000, more preferably 300 to 4,000, and still more preferably 350 to 3,500. When the weight average molecular weight exceeds 5,000 and is too large, there will be When the solubility to the solvent decreases and the handleability decreases, the weight average molecular weight is less than 250 and is too small. In the case of thermal curing, the curing is insufficient and the solvent resistance and heat resistance may decrease.

本發明中,(B)成分之三聚氰胺甲醛樹脂可以液體形態、或亦可以使純化之液體再溶解於後述溶劑中之溶液形態使用。 In the present invention, the melamine formaldehyde resin of the component (B) may be used in the form of a liquid or a solution in which the purified liquid is redissolved in a solvent described later.

另外,本發明中,(B)成分之三聚氰胺甲醛樹脂亦可為複數種(B)成分之三聚氰胺甲醛樹脂之混合物。 In addition, in the present invention, the melamine formaldehyde resin of component (B) may be a mixture of a plurality of melamine formaldehyde resins of component (B).

(B)成分之特定聚合物之較佳一例的酚酚醛清漆樹脂列舉為例如酚-甲醛聚縮合物等。 (B) The phenol novolak resin which is a preferable example of the specific polymer of a component is mentioned, for example, a phenol-formaldehyde polycondensate, etc.

本實施形態之硬化膜形成組成物中,(B)成分之聚合物可以粉體形態、或亦可以使純化之粉末再溶解於後述溶劑中之溶液形態使用。 In the cured film forming composition of the present embodiment, the polymer of component (B) may be used in the form of powder or a solution in which the purified powder is redissolved in a solvent described later.

另外,本實施形態之硬化膜形成組成物中,(B)成分之聚合物亦可為(B)成分之聚合物之複數種的混合物。 In addition, in the cured film forming composition of the present embodiment, the polymer of component (B) may be a mixture of plural kinds of polymers of component (B).

〈(C)成分〉 <(C) ingredient>

本實施形態之硬化膜形成組成物中含有之(C)成分為具有胺基之烷氧基矽烷化合物。 The component (C) contained in the cured film forming composition of this embodiment is an alkoxysilane compound having an amine group.

具有胺基之烷氧基矽烷化合物之具體例列舉為N,N’-雙[3-(三甲氧基矽烷基)丙基]-1,2-乙烷二胺、N,N’-雙[3-(三乙氧基矽烷基)丙基]-1,2-乙烷二胺、N- [3-(三甲氧基矽烷基)丙基]-1,2-乙烷二胺、N-[3-(三乙氧基矽烷基)丙基]-1,2-乙烷二胺、雙-{3-(三甲氧基矽烷基)丙基}胺、雙-{3-(三乙氧基矽烷基)丙基}胺、3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、三甲氧基{3-(甲基胺基)丙基}矽烷、3-(N-烯丙基胺基)丙基三甲氧基矽烷、3-(N-烯丙基胺基)丙基三乙氧基矽烷、3-(二乙胺基)丙基三甲氧基矽烷、3-(二乙胺基)丙基三乙氧基矽烷、3-(苯基胺基)丙基三甲氧基矽烷、3-(苯基胺基)丙基三乙氧基矽烷等化合物。 Specific examples of alkoxysilane compounds having an amine group are N, N'-bis [3- (trimethoxysilyl) propyl] -1,2-ethanediamine, N, N'-bis [ 3- (triethoxysilyl) propyl] -1,2-ethanediamine, N- [3- (trimethoxysilyl) propyl] -1,2-ethanediamine, N- [3- (triethoxysilyl) propyl] -1,2-ethanediamine, bis -{3- (trimethoxysilyl) propyl} amine, bis- {3- (triethoxysilyl) propyl} amine, 3-aminopropyltrimethoxysilane, 3-aminopropyl Triethoxysilane, trimethoxy {3- (methylamino) propyl} silane, 3- (N-allylamino) propyltrimethoxysilane, 3- (N-allyl Amino) propyltriethoxysilane, 3- (diethylamino) propyltrimethoxysilane, 3- (diethylamino) propyltriethoxysilane, 3- (phenylamino) Compounds such as propyltrimethoxysilane, 3- (phenylamino) propyltriethoxysilane.

該等具有胺基之烷氧基矽烷化合物可單獨使用或組合2種以上使用。 These alkoxysilane compounds having an amine group can be used alone or in combination of two or more.

本實施形態之硬化膜形成組成物中之(C)成分的具有胺基之烷氧基矽烷化合物之含量,基於(A)成分之化合物與(B)成分之聚合物之合計量之100質量份,較好為10質量份至100質量份,更好為15質量份至80質量份。(C)成分之具有胺基之烷氧基矽烷化合物之含量過小時,由硬化膜形成組成物所得之硬化膜之耐溶劑性及耐熱性降低,且光配向時之感度降低。另外,含量過大時,會有光配向性及保存安定性降低之情況。 The content of the alkoxysilane compound having an amine group in the component (C) in the cured film forming composition of this embodiment is 100 parts by mass based on the total amount of the compound in the component (A) and the polymer in the component (B) It is preferably 10 parts by mass to 100 parts by mass, more preferably 15 parts by mass to 80 parts by mass. (C) When the content of the alkoxysilane compound having an amine group of the component is too small, the solvent resistance and heat resistance of the cured film obtained from the cured film forming composition are reduced, and the sensitivity during light alignment is reduced. In addition, when the content is too large, the light alignment and storage stability may decrease.

〈溶劑〉 <Solvent>

本實施形態之硬化膜形成組成物主要以溶解於溶劑中之溶液狀態使用。此時使用之溶劑只要是可使(A)成分、(B)成分及(C)成分、及/或後述之其他添加劑溶 解即可,其種類及構造等並無特別限制。 The cured film forming composition of this embodiment is mainly used in the state of a solution dissolved in a solvent. As long as the solvent used at this time can dissolve (A) component, (B) component and (C) component, and / or other additives mentioned later The solution is sufficient, and the type and structure are not particularly limited.

溶劑之具體例列舉為例如乙二醇單甲基醚、乙二醇單乙基醚、甲基溶纖素乙酸酯、乙基溶纖素乙酸酯、二乙二醇單甲基醚、二乙二醇單乙基醚、丙二醇、丙二醇單甲基醚、丙二醇單甲基醚乙酸酯、丙二醇丙基醚乙酸酯、甲苯、二甲苯、甲基乙基酮、環戊酮、環己酮、2-丁酮、3-甲基-2-戊酮、2-戊酮、2-己酮、γ-丁內酯、2-羥基丙酸乙酯、2-羥基-2-甲基丙酸乙酯、乙氧基乙酸乙酯、羥基乙酸乙酯、2-羥基-3-甲基丁酸甲酯、3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸乙酯、3-乙氧基丙酸甲酯、丙酮酸甲酯、丙酮酸乙酯、乙酸乙酯、乙酸丁酯、乳酸乙酯、乳酸丁酯、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、及N-甲基吡咯烷酮等。 Specific examples of the solvent include, for example, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, Diethylene glycol monoethyl ether, propylene glycol, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol propyl ether acetate, toluene, xylene, methyl ethyl ketone, cyclopentanone, cyclic Hexanone, 2-butanone, 3-methyl-2-pentanone, 2-pentanone, 2-hexanone, γ-butyrolactone, ethyl 2-hydroxypropionate, 2-hydroxy-2-methyl Ethyl propionate, ethyl ethoxyacetate, ethyl hydroxyacetate, methyl 2-hydroxy-3-methylbutyrate, methyl 3-methoxypropionate, ethyl 3-methoxypropionate, Ethyl 3-ethoxypropionate, methyl 3-ethoxypropionate, methyl pyruvate, ethyl pyruvate, ethyl acetate, butyl acetate, ethyl lactate, butyl lactate, N, N- Dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone, etc.

該等溶劑可單獨使用1種或組合2種以上使用。 These solvents can be used alone or in combination of two or more.

〈其他添加劑〉 <Other additives>

另外,本實施形態之硬化膜形成組成物,只要不損及本發明之效果,則亦可視需要含有增感劑、矽烷偶合劑、界面活性劑、流變調整劑、顏料、染料、保存安定劑、消泡劑、抗氧化劑等。 In addition, the cured film-forming composition of this embodiment may contain a sensitizer, a silane coupling agent, a surfactant, a rheology modifier, a pigment, a dye, and a storage stabilizer as long as it does not impair the effect of the present invention , Antifoaming agent, antioxidant, etc.

例如,增感劑在使用本實施形態之硬化膜形成組成物形成熱硬化膜後,可有效促進光反應。 For example, the sensitizer can effectively promote the light reaction after forming the thermosetting film using the cured film forming composition of the present embodiment.

其他添加劑之一例的增感劑舉例為二苯甲 酮、蒽、蒽醌、噻噸酮等及其衍生物,以及硝基苯基化合物等。該等中,以二苯甲酮衍生物及硝基苯基化合物較佳。較佳之化合物之具體例列舉為N,N-二乙基胺基二苯甲酮、2-硝基茀、2-硝基茀酮、5-硝基苊、4-硝基聯苯、4-硝基桂皮酸、4-硝基二苯乙烯、4-硝基二苯甲酮、5-硝基吲哚等。尤其,以二苯甲酮之衍生物的N,N-二乙基胺基二苯甲酮最佳。 One example of other additives is a sensitizer such as dibenzoyl Ketone, anthracene, anthraquinone, thioxanthone and their derivatives, and nitrophenyl compounds. Among these, benzophenone derivatives and nitrophenyl compounds are preferred. Specific examples of preferred compounds are N, N-diethylaminobenzophenone, 2-nitrostilbene, 2-nitrostilbene, 5-nitroacenaphthene, 4-nitrobiphenyl, 4- Nitrocinnamic acid, 4-nitrostilbene, 4-nitrobenzophenone, 5-nitroindole, etc. In particular, N, N-diethylaminobenzophenone, which is a benzophenone derivative, is the best.

該等增感劑並不限於上述者。又,增感劑可單獨或組合2種以上之化合物併用。 Such sensitizers are not limited to the above. In addition, the sensitizer may be used alone or in combination of two or more compounds.

本實施形態之硬化膜形成組成物中之增感劑之使用比例,相對於(A)成分之特定共聚物與(B)成分之丙烯酸聚合物之合計質量之100質量份,較好為0.1質量份至20質量份,更好為0.2質量份至10質量份。其比例過小時,會有無法充分獲得作為增感劑之效果之情況,過大時會有發生透射率降低及塗膜粗糙之情況。 The use ratio of the sensitizer in the cured film forming composition of this embodiment is preferably 0.1 mass with respect to 100 mass parts of the total mass of the specific copolymer of component (A) and the acrylic polymer of component (B). Parts to 20 parts by mass, more preferably 0.2 parts to 10 parts by mass. If the ratio is too small, the effect as a sensitizer may not be sufficiently obtained. If it is too large, the transmittance may decrease and the coating film may be rough.

〈硬化膜形成組成物之調製〉 <Preparation of hardened film forming composition>

本實施形態之硬化膜形成組成物含有(A)成分的低分子之光配向成分、(B)成分的比(A)成分之光配向性成分更具親水性之聚合物、及(C)成分之具有胺基之烷氧基矽烷化合物。而且,只要不損及本發明效果,亦可含有其他添加劑。 The cured film-forming composition of this embodiment contains a low-molecular photo-alignment component of (A) component, a component (B) which is more hydrophilic than a photo-alignment component of (A) component, and (C) The alkoxysilane compounds with amine groups. Moreover, as long as the effect of the present invention is not impaired, other additives may be contained.

(A)成分與(B)成分之調配比以質量比計,較好為5:95至60:40。(B)成分之含量過大時液 晶配向性易降低,過小時因耐溶劑性降低而易使配向性降低。 The compounding ratio of (A) component and (B) component is a mass ratio, Preferably it is 5:95 to 60:40. (B) When the content of ingredients is too large The crystal alignment tends to decrease, and if it is too small, the alignment tends to decrease due to the reduced solvent resistance.

本實施形態之硬化膜形成組成物之較佳例如下。 Preferred examples of the cured film forming composition of this embodiment are as follows.

[1]:(A)成分與(B)成分之調配比以質量比計為5:95至60:40,基於(A)成分與(B)成分之合計量100質量份,含有10質量份至100質量份之(C)成分之硬化膜形成組成物。 [1]: The mixing ratio of (A) component and (B) component is 5:95 to 60:40 in terms of mass ratio, based on the total of 100 parts by mass of (A) component and (B) component, and contains 10 parts by mass Up to 100 parts by mass of the (C) component hardened film forming composition.

[2]:基於(A)成分與(B)成分之合計量100質量份,含有10質量份至100質量份之(C)成分、溶劑之硬化膜形成組成物。 [2]: Based on 100 parts by mass of the total of (A) component and (B) component, a cured film forming composition containing 10 to 100 parts by mass of (C) component and a solvent.

以溶液使用本實施形態之硬化膜形成組成物時之調配比例、調製方法等詳述於下。 The formulation ratio and preparation method when the cured film forming composition of this embodiment is used as a solution are described in detail below.

本實施形態之硬化膜形成組成物中之固體成分比例只要可使各成分均勻地溶解於溶劑中,即沒有特別限制,但可為1質量%至80質量%,較好為3質量%至60質量%,更好為5質量%至40質量%。此處,所謂固體成分係指自硬化膜形成組成物之全部成分去除溶劑者。 The solid content ratio in the cured film forming composition of the present embodiment is not particularly limited as long as each component can be uniformly dissolved in the solvent, but may be 1% by mass to 80% by mass, preferably 3% by mass to 60 The mass%, more preferably 5 mass% to 40 mass%. Here, the solid content means a solvent from all components of the cured film forming composition.

本實施形態之硬化膜形成組成物之調製方法並無特別限制。至於調製方法列舉為例如以特定之比例將(A)成分及(C)成分混合於溶解於溶劑中而成之(B)成分之溶液中,成為均勻溶液之方法,或在該調製法之適當階段中,視需要進一步添加其他添加劑並混合之方法。 The method for preparing the cured film forming composition of this embodiment is not particularly limited. The preparation method is, for example, a method of mixing (A) component and (C) component in a solution of (B) component dissolved in a solvent at a specific ratio to become a uniform solution, or appropriate in the preparation method In this stage, other additives are added and mixed as needed.

本實施形態之硬化膜形成組成物之調製中, 藉由溶劑中之聚合反應所得之特定共聚物之溶液可直接使用。該情況下,例如與前述同樣地將(A)成分與(C)成分饋入使具有聚乙二醇酯基之單體及具有碳數2~5之羥基烷基酯基之單體中之至少一者,與具有羧基之單體及具有酚性羥基之單體中之至少一者共聚合獲得之(B)成分之溶液中,成為均勻溶液。此時,為調整濃度亦可進一步追加投入溶劑。此時,(B)成分之生成過程中所用之溶劑與硬化膜形成組成物之濃度調整所用之溶劑可相同亦可不同。 In the preparation of the cured film forming composition of this embodiment, The solution of the specific copolymer obtained by the polymerization reaction in the solvent can be directly used. In this case, for example, the components (A) and (C) are fed into the monomer having a polyethylene glycol ester group and the monomer having a hydroxyalkyl ester group having 2 to 5 carbon atoms in the same manner as described above At least one of the solutions of the component (B) obtained by copolymerization with at least one of the monomer having a carboxyl group and the monomer having a phenolic hydroxyl group becomes a uniform solution. At this time, in order to adjust the concentration, a solvent may be further added. At this time, the solvent used in the production process of the component (B) and the solvent used for adjusting the concentration of the cured film forming composition may be the same or different.

另外,所調製之硬化膜形成組成物之溶液較好使用孔徑為0.2μm左右之過濾器等過濾後使用。 In addition, the prepared solution of the cured film-forming composition is preferably used after being filtered using a filter or the like having a pore diameter of about 0.2 μm.

〈硬化膜、配向材及相位差材〉 <Hardened film, alignment material and phase difference material>

以塗佈棒塗佈、旋轉塗佈、流動塗佈、輥塗佈、狹縫塗佈、繼狹縫塗佈後旋轉塗佈、噴墨塗佈、印刷等,將本實施形態之硬化膜形成組成物之溶液塗佈於基板(例如,矽/被覆二氧化矽之基板、氮化矽基板、被覆有金屬例如鋁、鉬、鉻等之基板、玻璃基板、石英基板、ITO基板等)或薄膜(例如三乙醯基纖維素(TAC)膜、環烯烴聚合物膜、聚對苯二甲酸乙二酯膜、丙烯酸膜等樹脂薄膜)等之上,隨後,以加熱板或烘箱等加熱乾燥,可形成硬化膜。 The cured film of this embodiment is formed by coating bar coating, spin coating, flow coating, roll coating, slit coating, spin coating after slit coating, inkjet coating, printing, etc. The solution of the composition is applied to a substrate (for example, a silicon / silicon dioxide coated substrate, a silicon nitride substrate, a substrate coated with a metal such as aluminum, molybdenum, chromium, etc., a glass substrate, a quartz substrate, an ITO substrate, etc.) or a thin film (For example, resin films such as triethyl acetyl cellulose (TAC) film, cycloolefin polymer film, polyethylene terephthalate film, acrylic film, etc.), etc., followed by heating and drying with a hot plate or oven, etc., A hardened film can be formed.

加熱乾燥之條件只要是不使由硬化膜形成之配向材之成分溶出於塗佈於其上之聚合性液晶溶液中之程 度地,以交聯劑進行交聯反應即可,例如採用在溫度60℃至200℃,時間0.4分鐘至60分鐘之範圍中適當選擇之加熱溫度及加熱時間。加熱溫度及加熱時間較好為70℃至160℃,0.5分鐘至10分鐘。 The conditions for heating and drying are as long as the components of the alignment material formed by the cured film are not dissolved in the polymerizable liquid crystal solution coated thereon The crosslinking reaction may be carried out with a crosslinking agent, for example, a heating temperature and a heating time appropriately selected in the range of a temperature of 60 ° C. to 200 ° C. and a time of 0.4 minutes to 60 minutes are used. The heating temperature and heating time are preferably 70 ° C to 160 ° C, and 0.5 minutes to 10 minutes.

使用本實施形態之硬化性組成物形成之硬化膜之膜厚例如為0.05μm至5μm,可考慮使用之基板之階差或光學、電性質來適當選擇。 The thickness of the cured film formed using the curable composition of this embodiment is, for example, 0.05 μm to 5 μm, and can be appropriately selected in consideration of the step difference, optical, and electrical properties of the substrate used.

如此形成之硬化膜可藉由進行偏光UV照射而可發揮作為配向材,亦即作為使液晶等具有液晶性之化合物配向之構件之功能。 The cured film thus formed can function as an alignment material, that is, as a member for aligning a liquid crystal compound such as liquid crystal by polarized UV irradiation.

偏光UV之照射方法通常使用150nm至450nm之波長之紫外光至可見光,在室溫或加熱狀態下自垂直或傾斜方向照射直線偏光而進行。 The method of irradiating polarized UV generally uses ultraviolet light with a wavelength of 150 nm to 450 nm to visible light, and irradiates linear polarized light from a vertical or oblique direction at room temperature or under heating.

由本實施形態之硬化膜組成物形成之配向材由於具有耐溶劑性及耐熱性,故將由聚合性液晶溶液所成之相位差材料塗佈於該配向材上後,藉由加熱至液晶之相轉移溫度使相位差材料成為液晶狀態,於配向材上配向。接著,可使成為配向狀態之相位差材料直接硬化,形成相位差材作為具有光學異向性之層。 Since the alignment material formed from the cured film composition of this embodiment has solvent resistance and heat resistance, after applying a phase difference material made of a polymerizable liquid crystal solution to the alignment material, it is heated to the phase transition of the liquid crystal The temperature makes the phase difference material into a liquid crystal state, and aligns on the alignment material. Next, the phase difference material in the alignment state can be directly cured to form the phase difference material as an optically anisotropic layer.

至於相位差材料係使用例如具有聚合性基之液晶單體及含有其之組成物等。而且,形成配向材之基板為薄膜時,具有本實施形態之相位差材之薄膜可使用作為相位差薄膜。形成此種相位差材之相位差材料有成為液晶狀態,而於配向材上成為水平配向、膽固醇相配向、垂直 配向、混合配向等配向狀態者,可分別依據必要之相位差使用。 As for the phase difference material, for example, a liquid crystal monomer having a polymerizable group and a composition containing the same are used. Furthermore, when the substrate on which the alignment material is formed is a thin film, the film having the phase difference material of this embodiment can be used as a phase difference film. The phase difference material forming such a phase difference material may be in a liquid crystal state, and on the alignment material, it may become horizontal alignment, cholesterol phase alignment, and vertical The alignment states such as alignment and mixed alignment can be used according to the necessary phase difference.

另外,製造3D顯示器所用之圖型化相位差材時,對由本實施形態之硬化膜組成物以上述方法形成之硬化膜,介隔線與間隔圖型之遮罩基於特定基準,以例如+45度方向進行偏光UV曝光,接著卸除遮罩後以-45度之方向進行偏光UV曝光,獲得形成有液晶之配向控制方向不同之2種液晶配向區域之配向材。隨後,塗佈由聚合性液晶溶液所成之相位差材料後,加熱至液晶之相轉移溫度使相位差材料成為液晶狀態,於配向材上配向。接著,使成為配向狀態之相位差材料直接硬化,分別複數、規則地配置相位差特性不同之2種相位差區域,可獲得圖型化之相位差材。 In addition, when manufacturing the patterned phase difference material used in the 3D display, for the cured film formed by the cured film composition of this embodiment by the above method, the mask between the intervening line and the space pattern is based on a specific standard, for example +45 Polarized UV exposure is performed in the direction of the degree, and then the mask is removed and polarized UV exposure is performed in the direction of -45 degrees to obtain an alignment material in which two types of liquid crystal alignment regions with different alignment control directions of liquid crystal are formed. Subsequently, after coating the phase difference material made of the polymerizable liquid crystal solution, it is heated to the phase transition temperature of the liquid crystal to make the phase difference material into a liquid crystal state, and is aligned on the alignment material. Next, the phase difference material in the alignment state is directly hardened, and two types of phase difference regions having different phase difference characteristics are arranged plurally and regularly, and a patterned phase difference material can be obtained.

另外,亦可使用如上述般形成之具有本實施形態之配向材之2片基板,介隔間隔使兩基板上之配向材相互對向貼合後,於該等基板之間注入液晶,使液晶配向成為液晶顯示元件。 In addition, two substrates with the alignment material of this embodiment formed as described above may also be used. After the alignment materials on the two substrates are laminated to face each other with a gap in between, liquid crystal is injected between the substrates to make The alignment becomes a liquid crystal display element.

因此,本實施形態之硬化膜形成組成物可較好地使用於各種相位差材(相位差薄膜)或液晶顯示元件等之製造。 Therefore, the cured film forming composition of the present embodiment can be preferably used in the manufacture of various retardation materials (retardation films), liquid crystal display elements, and the like.

實施例 Examples

以下列舉實施例,更詳細說明本實施形態,但本實施型態不受限於該等實施例。 The embodiments are listed below to explain the present embodiment in more detail, but the present embodiment is not limited to these embodiments.

[實施例中使用之縮寫] [Acronym used in Examples]

以下之實施例中使用之所寫意義如下。 The meanings used in the following examples are as follows.

〈具有光配向性基與羥基之化合物〉 <Compound with photo-alignment group and hydroxyl group>

C1N1:4-羥基己氧基桂皮酸甲酯 C1N1: 4-hydroxyhexyloxycinnamate

C1N2:3-甲氧基-4-羥基己氧基桂皮酸甲酯 C1N2: 3-methoxy-4-hydroxyhexyloxycinnamate

〈特定聚合物原料〉 <Specific polymer raw materials>

MAA:甲基丙烯酸 MAA: methacrylic acid

MMA:甲基丙烯酸甲酯 MMA: methyl methacrylate

HEMA:甲基丙烯酸2-羥基乙酯 HEMA: 2-hydroxyethyl methacrylate

AIBN:α,α’-偶氮雙異丁腈 AIBN: α, α’-azobisisobutyronitrile

HPCEL:羥基丙基纖維素 HPCEL: hydroxypropyl cellulose

AADEG:聚酯(己二酸/二乙二醇) AADEG: polyester (adipic acid / diethylene glycol)

〈具有胺基之烷氧基矽烷化合物〉 <Alkoxy Silane Compound with Amino Group>

BTESA:雙-{3-(三乙氧基矽烷基)丙基}胺 BTESA: bis- {3- (triethoxysilyl) propyl} amine

BTMSA:雙-{3-(三甲氧基矽烷基)丙基}胺 BTMSA: bis- {3- (trimethoxysilyl) propyl} amine

〈不具有胺基之烷氧基矽烷化合物〉 <Alkoxysilane compounds without amine groups>

BTESE:雙三乙氧基矽烷基乙烷 BTESE: Bistriethoxysilylethane

BTESAC:N,N’-雙[(3-三乙氧基矽烷基丙基)胺基羰基]聚環氧乙烷 BTESAC: N, N’-bis [(3-triethoxysilylpropyl) aminocarbonyl] polyethylene oxide

〈溶劑〉 <Solvent>

PM:丙二醇單甲基醚 PM: Propylene glycol monomethyl ether

根據以下合成例所得之丙烯酸共聚物之數平均分子量及重量平均分子量係使用日本分光(股)製造之GPC裝置(Shodex(註冊商標)管柱KF803L及KF804L),使溶出溶劑四氫呋喃以流量1mL/分鐘流入管柱(管柱溫度40℃)中溶離之條件進行測定。又,下述之數平均分子量(以下稱為Mn)及重量平均分子量(以下稱為Mw)係以聚苯乙烯換算值表示。 The number-average molecular weight and weight-average molecular weight of the acrylic copolymer obtained according to the following synthesis examples are using a GPC device (Shodex (registered trademark) columns KF803L and KF804L) manufactured by Japan Spectroscopy Co., Ltd., and the elution solvent tetrahydrofuran is flowed at 1 mL / min The conditions of dissolution in the column (column temperature 40 ° C) were measured. The following number average molecular weight (hereinafter referred to as Mn) and weight average molecular weight (hereinafter referred to as Mw) are expressed in terms of polystyrene conversion.

〈合成例1〉 <Synthesis Example 1>

將MAA 2.5g、MMA 9.2g、HEMA 5.0g、作為聚合觸媒之AIBN 0.2g溶解於PM 50.7g中,於70℃反應20小時,藉此獲得丙烯酸共聚物溶液(固體成分濃度25質量%)(P1)。所得丙烯酸共聚物之Mn為19,600,Mw為45,200。 MAA 2.5g, MMA 9.2g, HEMA 5.0g, and AIBN 0.2g as polymerization catalyst were dissolved in PM 50.7g and reacted at 70 ° C for 20 hours to obtain an acrylic copolymer solution (solid content concentration 25% by mass) (P1). Mn of the obtained acrylic copolymer was 19,600 and Mw was 45,200.

〈實施例1至5、比較例1、2〉 <Examples 1 to 5, Comparative Examples 1, 2>

以表1所示之組成調製實施例1至5之各硬化膜形成組成物,且針對各組成物進行密著性、配向感度、圖型形成性、透射率之評價。 Each cured film-forming composition of Examples 1 to 5 was prepared with the composition shown in Table 1, and the adhesion, alignment sensitivity, pattern-forming property, and transmittance were evaluated for each composition.

[密著性之評價] [Evaluation of adhesion]

使用旋轉塗佈器以2000rpm將實施例及比較例之各硬化膜形成組成物於鹼玻璃上旋轉塗佈30秒後,在溫度110℃以熱循環式烘箱進行加熱乾燥120秒形成硬化膜。對該硬化膜垂直照射50mJ/cm2之313nm之直線偏光。使用旋轉塗佈器將MURCK股份有限公司製之水平配向用聚合性液晶溶液RMS03-013C塗佈於曝光後之基板上之配向材上,接著,在60℃之加熱板上進行預烘烤60秒,形成膜厚1.0μm之塗膜。以1000mJ/cm2使該薄膜曝光,製作相位差材。使用切割刀對所得基板上之相位差材進行十字切割(1mm×1mm×100格),隨後,貼上透明膠帶,接著,計算將該透明膠帶剝離時基板上之膜未被剝離而殘留之格塊個數。膜未被剝離而殘留之格塊殘留90個以上者判斷為密著性良好。 Each of the cured film forming compositions of Examples and Comparative Examples was spin coated on the alkali glass using a spin coater at 2000 rpm for 30 seconds, and then heated and dried in a thermal circulation oven at a temperature of 110 ° C. for 120 seconds to form a cured film. The cured film was vertically irradiated with linear polarized light of 313 nm at 50 mJ / cm 2 . The horizontal alignment polymerizable liquid crystal solution RMS03-013C manufactured by MURCK Co., Ltd. was applied to the alignment material on the exposed substrate using a spin coater, and then pre-baked on a 60 ° C hot plate for 60 seconds To form a coating film with a thickness of 1.0 μm. The film was exposed at 1000 mJ / cm 2 to produce a phase difference material. Use a dicing knife to cross-cut the phase difference material on the obtained substrate (1mm × 1mm × 100 grids), and then apply a transparent tape, and then calculate the grid that the film on the substrate is not peeled off when the transparent tape is peeled off Number of blocks. If the film was not peeled off and 90 or more blocks remained, it was judged that the adhesion was good.

[配向感度之評價] [Evaluation of alignment sensitivity]

使用旋轉塗佈器以2000rpm將實施例及比較例之各硬化膜形成組成物於鹼玻璃上旋轉塗佈30秒後,於溫度110℃在熱循環式烘箱中進行加熱乾燥120秒形成硬化膜。對該硬化膜垂直照射313nm之直線偏光,形成配向材。使用旋轉塗佈器將MURCK股份有限公司製之水平配向用聚合性液晶溶液RMS03-013C塗佈於基板上之配向材上,接著,在60℃之加熱板上進行預烘烤60秒,形成膜厚1.0μm之塗膜。以1000mJ/cm2使該基板上之薄膜曝光,製作相位差材。以一對偏光板夾持所製作之基板上之相位差材,觀察相位差材中之相位差特性之展現狀況,以配向材顯示液晶配向性之必要偏光UV之曝光量作為配向感度。 Each of the cured film forming compositions of Examples and Comparative Examples was spin coated on the alkali glass using a spin coater at 2000 rpm for 30 seconds, and then heated and dried in a thermal circulation oven at a temperature of 110 ° C. for 120 seconds to form a cured film. The cured film was vertically irradiated with linear polarized light of 313 nm to form an alignment material. Using a spin coater, the horizontal alignment polymerizable liquid crystal solution RMS03-013C manufactured by MURCK Co., Ltd. was applied to the alignment material on the substrate, followed by pre-baking on a 60 ° C hot plate for 60 seconds to form a film A coating film with a thickness of 1.0 μm. The film on the substrate was exposed at 1000 mJ / cm 2 to produce a phase difference material. A pair of polarizing plates sandwich the phase difference material on the manufactured substrate to observe the development of the phase difference characteristics in the phase difference material, and the exposure amount of polarized UV necessary for the alignment material to show the liquid crystal alignment is used as the alignment sensitivity.

[圖型形成性之評價] [Evaluation of pattern formation]

使用旋轉塗佈器以2000rpm將實施例及比較例之各硬化膜形成組成物於鹼玻璃上旋轉塗佈30秒後,在溫度110℃以熱循環式烘箱進行加熱乾燥120秒形成硬化膜。介隔100μm之線與間隔之遮罩,對該硬化膜垂直照射30mJ/cm2之313nm之直線偏光。卸除遮罩,將基板旋轉90度後,垂直照射15mJ/cm2之313nm之直線偏光,獲得形成有液晶之配向控制方向相差90度之2種液晶配向區域之配向材。使用旋轉塗佈器將MURCK股份有限公司製 之水平配向用聚合性液晶溶液RMS03-013C塗佈於該基板上之配向材上,接著,在60℃之加熱板上進行預烘烤60秒,形成膜厚1.0μm之塗膜。以1000mJ/cm2使該基板上之薄膜曝光,製作圖型化相位差材。使用偏光顯微鏡觀察所製作之基板上之圖型化相位差材,形成無配向缺陷之相位差圖型者評價為○,見到配向缺陷者評價為×。 Each of the cured film forming compositions of Examples and Comparative Examples was spin coated on the alkali glass using a spin coater at 2000 rpm for 30 seconds, and then heated and dried in a thermal circulation oven at a temperature of 110 ° C. for 120 seconds to form a cured film. Through the mask of 100 μm line and space, the cured film was vertically irradiated with 30 mJ / cm 2 of 313 nm linear polarized light. After removing the mask, the substrate was rotated 90 degrees, and then vertically irradiated with 15mJ / cm 2 of 313nm linearly polarized light to obtain an alignment material in which two types of liquid crystal alignment regions differing by 90 degrees in the alignment control direction of the liquid crystal were formed. Using a spin coater, the horizontal alignment polymerizable liquid crystal solution RMS03-013C manufactured by MURCK Co., Ltd. was coated on the alignment material on the substrate, followed by pre-baking on a 60 ° C hot plate for 60 seconds to form A coating film with a thickness of 1.0 μm. The film on the substrate was exposed at 1000 mJ / cm 2 to produce a patterned retardation material. The patterned phase difference material on the produced substrate was observed with a polarizing microscope, and those who formed a phase difference pattern without alignment defects were evaluated as ○, and those who saw alignment defects were evaluated as ×.

[光透射率(透明性)之評價] [Evaluation of light transmittance (transparency)]

使用旋轉塗佈器以2000rpm將實施例及比較例之各硬化膜形成組成物於石英基板上旋轉塗佈30秒後,在溫度110℃於加熱板上進行加熱乾燥烘烤120秒,形成膜厚300nm之硬化膜。使用FILMETRICS公司製造之F20測定膜厚。使用紫外線可見光分光光度計(島津製作所(股)製造之SHIMADZU UV-2550型號),測定該硬化膜對波長400nm之光之透射率。 Using a spin coater at 2000 rpm, the cured film-forming compositions of the examples and comparative examples were spin-coated on a quartz substrate for 30 seconds, then heated and dried on a hot plate at a temperature of 110 ° C for 120 seconds to form a film thickness 300nm hardened film. The film thickness was measured using F20 manufactured by FILMETRICS. Using an ultraviolet visible light spectrophotometer (SHIMADZU UV-2550 model manufactured by Shimadzu Corporation), the transmittance of the cured film to light with a wavelength of 400 nm was measured.

[評價之結果] [Result of evaluation]

進行以上評價之結果示於表2。 The results of the above evaluations are shown in Table 2.

實施例1至5均以少的曝光量即顯示液晶配向性且顯示高配向感度,可進行光學圖型化。而且,顯示高透明性。 Examples 1 to 5 all exhibit liquid crystal alignment and a high alignment sensitivity with a small amount of exposure, and can be optically patterned. Moreover, it shows high transparency.

比較例1及2之配向感度低,難以進行光學圖型化。 Comparative Examples 1 and 2 have low alignment sensitivity, and it is difficult to pattern optical patterns.

[產業上之可利用性] [Industry availability]

本發明之硬化膜形成組成物於作為液晶顯示元件之液晶配向膜、或用以形成在液晶顯示元件之內部或外部所設之光學異向性薄膜之配向材方面極為有用,尤其,可較好地作為3D顯示器之圖型化相位差材之形成材料。另外,亦較好地作為形成薄膜電晶體(TFT)型液晶顯示元件或有機EL元件等各種顯示器中之保護膜、平坦化膜及絕緣膜等之硬化膜之材料,尤其是形成TFT型液晶元件之層間絕緣膜、彩色濾光片之保護膜或有機EL元件之絕緣膜等之材料。 The cured film forming composition of the present invention is extremely useful as a liquid crystal alignment film for a liquid crystal display element, or as an alignment material for forming an optically anisotropic film provided inside or outside the liquid crystal display element. It is used as the material for forming the patterned phase difference material of 3D display. In addition, it is also suitable as a material for forming a hardened film such as a protective film, a flattening film and an insulating film in various displays such as thin-film transistor (TFT) type liquid crystal display elements or organic EL elements, especially for forming TFT type liquid crystal elements Materials such as interlayer insulation film, color filter protection film or organic EL device insulation film.

Claims (11)

一種硬化膜形成組成物,其特徵係含有(A)具有光配向性基與2個以上之羥基之化合物、(B)具有由羥基、羧基及胺基選出之一種或兩種以上之取代基之親水性聚合物、以及(C)具有胺基之烷氧基矽烷化合物,基於(A)成分及(B)成分之合計量100質量份,含有10質量份~100質量份之(C)成分。A composition for forming a cured film, which is characterized by containing (A) a compound having a photo-alignment group and two or more hydroxyl groups, and (B) having one or more substituents selected from a hydroxyl group, a carboxyl group and an amine group The hydrophilic polymer and (C) alkoxysilane compound having an amine group contain 10 parts by mass to 100 parts by mass of component (C) based on 100 parts by mass of the total of the components (A) and (B). 如請求項1之硬化膜形成組成物,其中(A)成分之光配向性基為進行光二聚化或光異構化之構造的官能基。The cured film-forming composition according to claim 1, wherein the photo-alignment group of the component (A) is a functional group having a structure of performing photo-dimerization or photo-isomerization. 如請求項1或2之硬化膜形成組成物,其中(A)成分之光配向性基為桂皮醯基(cinnamoyl)。The composition for forming a hardened film according to claim 1 or 2, wherein the photo-alignment group of the component (A) is cinnamoyl. 如請求項1或2之硬化膜形成組成物,其中(A)成分之光配向性基為偶氮苯構造之基。The hardened film forming composition according to claim 1 or 2, wherein the photo-alignment group of the component (A) is a group of azobenzene structure. 如請求項1或2之硬化膜形成組成物,其中(B)成分為由聚醚多元醇、聚酯多元醇、聚碳酸酯多元醇及聚己內酯多元醇所組成群組選出之至少一種聚合物。The cured film forming composition according to claim 1 or 2, wherein component (B) is at least one selected from the group consisting of polyether polyol, polyester polyol, polycarbonate polyol and polycaprolactone polyol polymer. 如請求項1或2之硬化膜形成組成物,其中(B)成分為纖維素或其衍生物。The cured film-forming composition according to claim 1 or 2, wherein the component (B) is cellulose or a derivative thereof. 如請求項1或2之硬化膜形成組成物,其中(B)成分為具有聚乙二醇酯基及碳原子數2~5之羥基烷酯基中之至少一者,與羧基及酚性羥基中之至少一者之丙烯酸系聚合物。The cured film forming composition according to claim 1 or 2, wherein component (B) is at least one of a polyethylene glycol ester group and a hydroxyalkyl ester group having 2 to 5 carbon atoms, together with a carboxyl group and a phenolic hydroxyl group At least one of them is an acrylic polymer. 如請求項1或2之硬化膜形成組成物,其中(B)成分為環糊精或其衍生物。The hardened film forming composition according to claim 1 or 2, wherein the component (B) is cyclodextrin or a derivative thereof. 如請求項1或2之硬化膜形成組成物,其中(A)成分與(B)成分之比率以質量比計為5:95~60:40。The cured film forming composition according to claim 1 or 2, wherein the ratio of the component (A) to the component (B) is 5: 95 ~ 60: 40 in terms of mass ratio. 一種配向材,其特徵係使用如請求項1~9中任一項之硬化膜形成組成物所得。An alignment material characterized by using the cured film forming composition according to any one of claims 1 to 9. 一種相位差材,其特徵係使用由如請求項1~9中任一項之硬化膜形成組成物所得之硬化膜而形成。A phase difference material characterized by being formed using a cured film obtained from the cured film forming composition according to any one of claims 1 to 9.
TW102110902A 2012-03-28 2013-03-27 Cured film forming composition, alignment material and retardation material TWI627210B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012074014 2012-03-28
JP2012-074014 2012-03-28

Publications (2)

Publication Number Publication Date
TW201404816A TW201404816A (en) 2014-02-01
TWI627210B true TWI627210B (en) 2018-06-21

Family

ID=49259725

Family Applications (2)

Application Number Title Priority Date Filing Date
TW102110902A TWI627210B (en) 2012-03-28 2013-03-27 Cured film forming composition, alignment material and retardation material
TW106109788A TWI627214B (en) 2012-03-28 2013-03-27 Cured film forming composition, alignment material and retardation material

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW106109788A TWI627214B (en) 2012-03-28 2013-03-27 Cured film forming composition, alignment material and retardation material

Country Status (5)

Country Link
JP (1) JP6086115B2 (en)
KR (1) KR102097067B1 (en)
CN (1) CN104204120B (en)
TW (2) TWI627210B (en)
WO (1) WO2013146469A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102294744B1 (en) * 2012-10-24 2021-08-30 닛산 가가쿠 가부시키가이샤 Cured-film-forming composition, alignment material, and phase-difference material
TWI610976B (en) * 2012-12-27 2018-01-11 日產化學工業股份有限公司 Cured film forming composition, alignment material and retardation material
KR102243800B1 (en) 2013-03-08 2021-04-23 닛산 가가쿠 가부시키가이샤 Cured-film forming composition, alignment material, and retardation material
KR102296695B1 (en) * 2014-02-28 2021-09-02 닛산 가가쿠 가부시키가이샤 Phase difference material-forming resin composition, orientation material, and phase difference material
KR102587587B1 (en) * 2015-03-11 2023-10-11 닛산 가가쿠 가부시키가이샤 Cured film forming composition, orientation material and phase difference material
WO2016143860A1 (en) * 2015-03-11 2016-09-15 日産化学工業株式会社 Cured film-forming composition, alignment material and the phase difference material
EP3269781B1 (en) * 2015-03-13 2021-04-21 Nissan Chemical Corporation Cured-film-forming composition, alignment material, and phase difference material
KR20200135967A (en) * 2018-03-27 2020-12-04 닛산 가가쿠 가부시키가이샤 Cured film forming composition, alignment material, and retardation material
CN114746512B (en) * 2019-11-25 2023-09-22 日产化学株式会社 Composition for forming cured film, alignment material, and retardation material

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003160711A (en) * 2001-11-27 2003-06-06 Dainippon Ink & Chem Inc Thermosetting resin composition, protective film material for optical device, resin cured product and color filter
TW201211140A (en) * 2010-04-08 2012-03-16 Nissan Chemical Ind Ltd Thermosetting film forming composition having photo-alignment property

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6097324A (en) * 1983-10-31 1985-05-31 Sharp Corp Manufacture of liquid crystal display element
JPS611342A (en) 1984-06-14 1986-01-07 Noboru Yamada Smoking process
JPS61277921A (en) * 1985-05-31 1986-12-08 Nitto Electric Ind Co Ltd Production of liquid crystal sandwiching substrate
JP3767962B2 (en) 1997-02-19 2006-04-19 シャープ株式会社 Video display system
WO1999015576A1 (en) 1997-09-25 1999-04-01 Rolic Ag Photocrosslinkable polyimides
JPH11131013A (en) * 1997-10-31 1999-05-18 Hitachi Chem Co Ltd Resin composition for color filter protecting film, and color filter protecting film and color filter using the same
JP2000302792A (en) * 1999-04-19 2000-10-31 Ck Witco Corp Bis-silyl tertiary amines
JP2002241722A (en) * 2001-02-19 2002-08-28 Sumitomo Bakelite Co Ltd Anisotropic conductive adhesive
US7074344B2 (en) * 2001-10-03 2006-07-11 Jsr Corporation Liquid crystal aligning agent and liquid crystal display element
JP2005049865A (en) 2003-07-17 2005-02-24 Arisawa Mfg Co Ltd Manufacturing method of optical phase difference element
JP4128116B2 (en) * 2003-07-29 2008-07-30 旭化成エレクトロニクス株式会社 Positive photosensitive resin composition
JP2007009048A (en) * 2005-06-30 2007-01-18 Sumitomo Chemical Co Ltd Composition for forming insulating film and method for producing insulating film
JP2007092070A (en) * 2005-09-05 2007-04-12 Jts Kk Thermoset type aqueous ultra-violet ray protection paint, and ultra-violet light protection cut-glass bottle and plate glass
JP2009040984A (en) * 2007-08-13 2009-02-26 Dainippon Printing Co Ltd Liquid crystal composition, retardation-controlling members using the same, and liquid crystal display
JP5316740B2 (en) 2007-08-30 2013-10-16 Jsr株式会社 Method for forming liquid crystal alignment film
JP2009104065A (en) * 2007-10-25 2009-05-14 Nippon Zeon Co Ltd Luminance enhancing film and liquid crystal display device
WO2009133803A1 (en) * 2008-04-28 2009-11-05 Jsr株式会社 Liquid crystal aligning agent and method for forming liquid crystal alignment films
JP2010235786A (en) * 2009-03-31 2010-10-21 Aica Kogyo Co Ltd Modified silicone resin composition
WO2010117223A2 (en) * 2009-04-09 2010-10-14 주식회사 엘지화학 Alignment layer composition, alignment layer prepared with the same, preparation method of alignment layer, optical film containing the same, and display device including the optical film
JP5356928B2 (en) * 2009-06-17 2013-12-04 旭化成ケミカルズ株式会社 Photosensitive resin composition, and photosensitive inkjet ink, photosensitive adhesive, photosensitive coating agent, and semiconductor encapsulant using the same
WO2011010635A1 (en) * 2009-07-21 2011-01-27 日産化学工業株式会社 Composition forming heat cured film having photo alignment property
US9193861B2 (en) * 2010-04-08 2015-11-24 Nissan Chemical Industries, Ltd. Composition for forming thermoset film having photo-alignment properties

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003160711A (en) * 2001-11-27 2003-06-06 Dainippon Ink & Chem Inc Thermosetting resin composition, protective film material for optical device, resin cured product and color filter
TW201211140A (en) * 2010-04-08 2012-03-16 Nissan Chemical Ind Ltd Thermosetting film forming composition having photo-alignment property

Also Published As

Publication number Publication date
JP6086115B2 (en) 2017-03-01
JPWO2013146469A1 (en) 2015-12-10
CN104204120A (en) 2014-12-10
KR102097067B1 (en) 2020-04-03
KR20140142257A (en) 2014-12-11
TWI627214B (en) 2018-06-21
WO2013146469A1 (en) 2013-10-03
CN104204120B (en) 2017-03-08
TW201404816A (en) 2014-02-01
TW201726798A (en) 2017-08-01

Similar Documents

Publication Publication Date Title
TWI627210B (en) Cured film forming composition, alignment material and retardation material
JP6274441B2 (en) Cured film forming composition, alignment material and retardation material
JP6032438B2 (en) Cured film forming composition, alignment material and retardation material
JP6274442B2 (en) Cured film forming composition, alignment material and retardation material
JP6260790B2 (en) Alignment material manufacturing method, alignment material, retardation material manufacturing method, and retardation material
JP6458949B2 (en) Cured film forming composition, alignment material and retardation material
TWI499606B (en) Thermosetting film forming composition having photo-alignment property
JPWO2019189193A1 (en) Hardened film forming composition, alignment material and retardation material
TW202003672A (en) Cured film forming composition, alignment material and retardation material
WO2021106858A1 (en) Cured film-forming composition, alignment material, and phase difference material